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Background: To gain insight into what differences might restrict the capacity for limb regeneration in Xenopus
froglets, we used High Performance Liquid Chromatography (HPLC)/double mass spectrometry to characterize
protein expression during fibroblastema formation in the amputated froglet hindlimb, and compared the results to
those obtained previously for blastema formation in the axolotl limb.
Results: Comparison of the Xenopus fibroblastema and axolotl blastema revealed several similarities and significant
differences in proteomic profiles. The most significant similarity was the strong parallel down regulation of muscle
proteins and enzymes involved in carbohydrate metabolism. Regenerating Xenopus limbs differed significantly from
axolotl regenerating limbs in several ways: deficiency in the inositol phosphate/diacylglycerol signaling pathway,
down regulation of Wnt signaling, up regulation of extracellular matrix (ECM) proteins and proteins involved in
chondrocyte differentiation, lack of expression of a key cell cycle protein, ecotropic viral integration site 5 (EVI5),
that blocks mitosis in the axolotl, and the expression of several patterning proteins not seen in the axolotl that may
dorsalize the fibroblastema.
Conclusions: We have characterized global protein expression during fibroblastema formation after amputation of
the Xenopus froglet hindlimb and identified several differences that lead to signaling deficiency, failure to retard
mitosis, premature chondrocyte differentiation, and failure of dorsoventral axial asymmetry. These differences point
to possible interventions to improve blastema formation and pattern formation in the froglet limb.
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Urodeles regenerate perfect replicas of limb segments lost
by amputation at any proximodistal (PD) level throughout
their lives [1,2], for reviews, although the rate and com-
pleteness of regeneration are affected by factors such as
age and metamorphosis [3]. Regeneration is accomplished
by the formation of a blastema composed of progenitor
cells derived by reprogramming of differentiated cells
(dedifferentiation) and stem cells associated with skeletal
muscle and perhaps other tissues. Growth of the blastema* Correspondence: dstocum@iupui.edu
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unless otherwise stated.is driven by a nerve-dependent signaling center, the apical
epidermal cap (AEC) [4-8]. Global transcript analysis by
microarray and RNA-Seq has identified overlapping suites
of genes that include markers for stem and progenitor
cells, genes that define specific phases of regeneration,
genes that are regulated by neural signals, and genes that
differentiate regeneration from skin wound repair [9-11].
Nieuwkoop-Faber [12] stage 51–53 limb buds of the
anuran Xenopus laevis also regenerate perfectly at any
level of amputation. After NF stage 53, however, regene-
rative capacity becomes progressively hypomorphic and
spatially restricted to progressively more distal levels, until
by stage 56 or 57 amputation at any level results only in
the regeneration of a muscle-less, un-segmented cartilage
spike covered by an envelope of skin [13-15]. This. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Rao et al. BMC Developmental Biology 2014, 14:32 Page 2 of 27
http://www.biomedcentral.com/1471-213X/14/32spatiotemporal restriction of regenerative capacity is corre-
lated with the general proximal to distal ossification of
skeletal tissues, although regeneration is slightly better
when amputation is through the soft tissue of the joints
[16]. Loss of regenerative capacity during limb devel-
opment in Xenopus is due to intrinsic changes in limb
tissues, as shown by the fact that grafting regeneration-
competent blastemas to regeneration-deficient limb stumps
and vice versa does not alter the regenerative capacity of
the blastema [17,18].
The Xenopus and urodele limb regeneration blastema
share some features. Both rely on nerve-dependent sig-
nals from the wound epidermis for their formation and
growth [19-22]. Both express prx1, a transcription factor
that serves as an early marker of dedifferentiated cells
[23,24]. Most often, however, the Xenopus blastema is
described as a “fibroblastema” or “pseudoblastema”, as
opposed to the mesenchymal nature of the urodele blas-
tema. Although one study [25] reported that the morph-
ology and fine structure of the cells released by histolysis
is similar in amputated urodele and Xenopus limbs, most
studies suggest that, compared to the amputated urodele
limb, histolysis is limited in the amputated Xenopus limb,
there is little if any cellular dedifferentiation, progenitor
cells are fibroblastic rather than mesenchymal, muscle sat-
ellite cells do not contribute to the fibroblastema, neurovas-
cular invasion is sparser, and the AEC is thinner with a
connective tissue pad between it and the underlying cells
[13,16,20,26,27]. These features have been correlated with a
shift in the response to amputation brought about by the
maturation of the immune system as the tadpole differenti-
ates and undergoes metamorphosis [28-30].
Defining the cellular and molecular basis of the contrast
in regenerative ability between regeneration-competent
and regeneration-deficient limbs is of great interest, be-
cause of the potential to identify factors associated with
successful regeneration and/or the factors that inhibit
it. Differences in transcript expression by amputated
regeneration-competent Xenopus limb buds (stage 52/53)
vs. regeneration-deficient limbs (stage 57 or froglets) have
been reported for specific genes and for global gene arrays
compiled by subtractive hybridization or microarray
[31-34]. In particular, PD axial patterning genes such as
Hoxa9, Hoxa11, and Hoxa13 are expressed by the fibro-
blastemas of Xenopus limbs, but their expression is not
deployed in the proper spatiotemporal organization
characteristic of regeneration-competent blastemas [35].
Furthermore, regeneration-deficient Xenopus blastemas
fail to express shh, an important regulator of anteroposte-
rior (AP) axial patterning in axolotl limb buds and blaste-
mas and Xenopus stage 52 limb buds [31], a failure due to
the epigenetic hyper-methylation of an enhancer sequence
regulating shh expression [36]. These findings have led to
the idea that faulty expression of patterning genes is themajor cause of regenerative deficiency in Xenopus limbs
[35]. The reasons why Xenopus limb patterning genes are
not activated in their proper spatiotemporal pattern are
unknown, but are likely due to an inability to activate and/
or inhibit other processes necessary to the formation of a
regeneration-competent blastema.
Analysis of gene activity on the mRNA level excludes
post-transcriptional events that determine whether or
not specific transcripts are translated into protein and at
what rate. Transcript analysis has therefore been com-
plemented by proteomic analysis of regenerating am-
phibian limbs. Protein synthesis in regenerating newt
limbs has been studied by autoradiographic [37], biochem-
ical [38,39] and gel electrophoretic [40-43] methods. The
electrophoretic studies revealed differences in protein
composition at different stages of regeneration and be-
tween innervated and denervated limbs, but only a few
proteins were identifiable. Quantitative HPLC/mass
spec methods have enabled the identification of individual
proteins and their fold changes with respect to baseline
values. King et al. [44] compared the blastemal proteome
of stage 53 Xenopus limb buds at three days post-
amputation to un-amputated tissue and identified a
number of proteins with large fold changes. We have
assessed temporal quantitative changes in proteins
expressed during formation of the accumulation (early
bud) blastema of the regenerating axolotl hind limb
[45], and have conducted bioinformatic analysis to re-
veal pathways and networks of protein interactions dur-
ing blastema formation [46].
To gain insight into the proteomic differences between
blastema formation in regeneration-deficient Xenopus
and regeneration-competent axolotl limbs, we have con-
ducted a proteomic analysis of fibroblastema formation in
Xenopus froglets and compared the results to those we
obtained for blastema formation in the axolotl limb
[45]. This species comparison has advantages over com-
parisons between regeneration-competent stage 52/53
Xenopus tadpole limb buds vs. regeneration-deficient
stage 57-60 tadpole or froglet limbs in that we are compar-
ing the regeneration of fully differentiated, nerve-dependent
limbs rather than undifferentiated nerve-independent
limb buds vs. nerve-dependent differentiated limbs.
Results and discussion
Histology of fibroblastema formation in froglet hind limbs
At 1 dpa, the wound epidermis covered the clotted plasma
of the amputation surface with its blood cells and cellular
and tissue debris. By 5 dpa, the debris had been largely re-
moved by macrophages and tissue histolysis by proteolytic
degradation was underway. By 7 dpa, cells in the perios-
teum were activated for a considerable distance proximal
to the amputation plane, forming two thick collars of fi-
broblastic cells surrounding both tibia and fibula that
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under the wound epidermis. By 12 dpa (Figure 1), the col-
lar was differentiating into chondrocytes that graded into
a mound of fibroblastic cells representing an accumulation
fibroblastema. The fibroblastema grows as it simultan-
eously differentiates into chondrocytes in continuity with
the cartilage collar to form the cartilage spike that is the
characteristic end point of the regenerating froglet limb.
Xenopus protein expression
A total of 2500 Xenopus peptides were separated in the
samples. They fell into four priority groups according to
confidence in identification of proteins using a human
database. Priority groups 1 (P1, 601 proteins) and 2 (P2,
613 proteins met a statistical cutoff of >90% (see Methods
for further details). These 1214 proteins were filtered as
outlined in Methods to give 1014 identifiable proteins.
Collapsing duplicates and discarding proteins with no
known function yielded 830 proteins for analysis. The
remaining 1296 proteins fell into P3 and P4 categories
that did not meet the cutoff and were therefore not in-
cluded in the analysis. Figure 2 summarizes the distribution
of P1/P2 proteins according to their biological process and
Additional file 1: Table S1 lists all the P1/P2 proteins in
each of the ten biological process categories/sub-categories,Figure 1 Histological section of regenerating froglet hindlimb at 12 d
cut through the dorsoventral plane such that the tibia (T) and the accomp
collar (CC) has formed around the tibia for some distance proximal to the
the fibula. A fibroblastema (FB) that will form the cartilage spike is present
epidermal cap (arrow). Yellow line indicates the plane of tissue harvest.with fold change (FC) at each of the time points post-
amputation, and peptide sequence. Proteins that had
FC =/>2.0 are coded in yellow. Additional file 2: Figure
S1 illustrates global intensity maps of FC at 1, 5, 7 and
12 dpa for each category of biological process.
Eighty percent of the P1 and P2 Xenopus proteins were
up or down regulated at all post-amputation time points
or three of four time points in the combinatorial expres-
sion patterns summarized in Table 1. The number and
percentage of proteins in each biological process cat-
egory up or down regulated at either all four or three of
four time points, and the ratios of up to down regula-
tion, are summarized in Table 2. The overall ratio of up
regulated to down regulated proteins was 1.3. Up regula-
tion was heavily favored over down regulation in the cat-
egories of signaling, transcription, translation, non-muscle
cytoskeleton, ECM, and cell protection (particularly chap-
erones). Categories in which up regulation was moderately
or slightly favored over down regulation were degradation
and cell cycle. Down regulation was heavily favored in
three categories, intracellular transport, cytoskeleton (par-
ticularly sarcomeric proteins), and metabolism (particu-
larly carbohydrate metabolism).
Two hundred seventy-five proteins (33.6% of the total)
had positive or negative FC =/>2 on one or more dpa.ays post-amputation through the mid tibia-fibula. The section is
anying flexor and extensor muscle masses are visible (red). A cartilage
amputation plane that merges distally with a similar collar surrounding
between the merge point of the cartilage collars and the apical
Figure 2 Pie chart showing the percentage distribution of the 820 proteins among different biological categories and sub-categories.
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regulation, in the patterns shown in Table 1, for these pro-
teins in each biological process category, and Additional
file 3 lists the designations of these proteins. The U/D
ratio for these high FC proteins was highest (2–4) for
signaling, translation, ECM and non-muscle cytoskeleton;
intermediate (1–2) for transcription, cell protection, non-
carbohydrate metabolism, degradation, and cell cycle; and
lowest (<1) for intracellular transport, muscle cytoskel-
eton, and carbohydrate metabolism. Within the cytoskel-
eton category, U/D for muscle proteins was only 0.1
compared to non-muscle proteins at 3.7, and within the
metabolism category it was 0.3 for carbohydrates in con-
trast to 1.3 for non-carbohydrate.
Table 4 summarizes the number and percentage of
proteins with FC =/>2 as a function of dpa. About 56%
of these proteins have FC =/>2 at only one time point
after amputation, and this was at 12 dpa in the vastTable 1 Patterns of up or down regulation observed at all
four post-amputation time points or three of the four
time points
Up regulation Down regulation
1dpa 5 dpa 7 dpa 12 dpa 1 dpa 5 dpa 7 dpa 12 dpa
u u u u d d d d
d/n u u u u/n d d d
u u u d/n d d d u/n
u d/n u u d u/n d d
u u d/n u d d u/n d
u = up regulation, d = down regulation, n = no change. Slash means “or”;
dpa = days post-amputation.majority of cases. Proteins with FC =/>2 FC at two time
points (usually 7 and 12 dpa) or 3–4 time points (usually
5, 7, and 12 dpa) comprised about 22% each. Table 5
summarizes the number of high FC proteins at each
time point after amputation and their U/D ratios. The
U/D ratios in each biological process category either fluc-
tuated slightly or showed a rise in these ratios from 1-12
dpa. We reasoned that these 275 proteins would be the
ones most likely to be involved in fibroblastema forma-
tion, including hemostasis and re-epithelialization of the
amputation surface. Thus in comparing the formation of
the Xenopus fibroblastema with blastema formation in the
axolotl, we focused on the functions of these high FC pro-
teins, the details of which can be found in the Additional
file 4. At the same time, however, we paid attention to
some proteins with FC < 2 whose function suggested that
they might be relevant to the regenerative process.
Validation of Xenopus proteomic analysis
We fluorescently immunostained longitudinal cryosec-
tions of Xenopus limb tissue at each dpa to validate FC
data obtained by LC/MS/MS and quantitated the intensity
of fluorescence by densitometry (Figure 3). Three proteins
were validated: β1 integrin, vimentin, and β2 dystroglycan.
The immunofluorescent imaging and densitometry data
were in good agreement with the mass spectrometry data.
Comparison of froglet limb with axolotl limb
We compared the data on fibroblastema formation in
Xenopus with the data for blastema formation in the
axolotl [45] to determine whether there were prote-
omic differences that could be related to regenerative
Table 2 Number of Xenopus proteins in each biological
process category that are up regulated (U) or down
regulated (D) on all dpa or 3 of 4 dpa, and U/D ratios
Biological process Total
Category Proteins U D U/D
Signaling 93 49 (52.7) 31 (33.3) 1.6
Transport 67 30 (46.6) 32 (50.0) 0.9
VT 44 20 (45.5) 24 (54.5) 0.8
NVT 23 10 (43.5) 8 (34.8) 1.3
Transcription 104 51 (49.0) 36 (34.6) 1.4
Chromatin associated 24 13 (54.2) 7 (29.2) 1.9
Transcription factors 41 19 (46.3) 16 (39.0) 1.2
RNA processing 39 19 (48.7) 13 (33.3) 1.5
Translation 78 48 (62.8) 15 (20.6) 3.1
Ribosomal proteins 55 34 (61.8) 10 (18.2) 3.4
Translation factors 23 15 (60.9) 5 (21.7) 3.0
Cytoskeleton 104 40 (38.5) 41 (39.4) 0.9
Muscle 28 3 (10.7) 23 (82.1) 0.1
Non-Muscle 76 37 (53.0) 18 (21.0) 2.1
Extracellular matrix 41 25 (61.0) 4 (9.8) 6.3
Metabolism 135 39 (37.1) 68 (50.3) 0.7
Carbohydrate 72 16 (22.2) 39 (54.2 0.4
Non-Carbohydrate 63 23 (36.5) 29 (44.4) 0.8
Cell Protection 80 39 (48.70) 21 (26.3) 1.9
Inflamm-Related 38 16 (42.1) 11 (28.9) 1.5
Apoptosis-Related 10 5 (50.0) 5 (50.0) 1.0
Chaperones 32 18 (56.3) 5 (15.6) 3.6
Degradation 64 27 (42.2) 21 (32.8) 1.3
Ubiquit/Proteasome 29 11 (37.9) 10 (34.4) 1.1
Other 35 16 (45.7) 11 (31.4) 1.5
Cell cycle 54 21 (38.9) 18 (33.3) 1.2
G1/S 15 6 (40.0) 7 (46.7) 0.9
M 18 8 (44.4) 6 (33.4) 1.3
Other 21 7 (33.3) 5 (23.8) 1.4
Total 369 287 1.3
Numbers in parentheses indicate percentages of the total proteins up or
down regulated. VT = vesicle-associated transport and NVT
non-vesicle-associated transport.
Table 3 Number of Xenopus proteins up regulated (U) or
down regulated (D) with FC =/>2 at one or more time
points after amputation, and the ratio of U/D, according
to biological process category
Biological process U D U/D
Signaling 30 13 2.3
Transport 11 19 0.6
Transcription 24 21 1.1
Translation 6 2 3.0
Cytoskeleton 27 20 1.4
Muscle 1 13 0.1
Non-Muscle 26 7 3.7
Extracellular matrix 8 2 4.0
Metabolism 10 12 0.8
Carbohydrate 2 6 0.3
Non-Carbohydrate 8 6 1.3
Cell protection 11 9 1.2
Degradation 7 5 1.4
Cell cycle 12 9 1.3
G1/S 3 4 0.8
M 5 4 1.3
Other 4 1 4.0
Table 4 Percentage of up or down regulated Xenopus
proteins with FC =/>2 at one time point (TP), 2 time
points or 3–4 time points after amputation, according to
biological process category
Biological process 1 TP 2 TP 3-4 TP
Signaling 53.6 14.3 32.1
Transport 42.4 19.0 38.1
Transcription 48.8 20.9 30.2
Translation 66.6 33.3 00.0
Cytoskeleton 67.2 22.4 10.3
Muscle associated 68.8 18.8 12.5
Non-Muscle Associated 66.7 23.8 9.5
ECM 60.0 30.0 10.0
Metabolism 54.8 21.4 9.5
Carbohydrate 50.0 16.7 33.3
Non-Carbohydrate 0.57 33.3 13.3
Cell protection 38.1 14.3 47.6
Degradation 91.7 00.0 7.3
Ubiquit/Proteasome 85.7 00.0 14.3
Other 100.0 00.0 00.0
Cell cycle 33.3 33.3 33.3
G1/S 43.6 28.6 28.6
M 11.1 55.6 33.3
Other 60.0 00.0 40.0
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the froglet. The number of P1 and P2 proteins from the
Xenopus limb was 2.7 times greater than the axolotl limb.
This difference might be related to the greater degree of tis-
sue differentiation and density in the froglet hind limb and
the higher complexity in Xenopus of systems such as the
adaptive immune response that might affect the regenera-
tive process [30]. This difference in complexity is apparent
when the expression intensity maps are represented in cir-
cular fashion and lines drawn between interacting proteins,
Table 5 Number of highly regulated Xenopus proteins up
regulated and down regulated at each time point after
amputation and U/D ratios (bold)
11 dpa 5dpa 7 dpa 12 dpa
U D U/D U D U/D U D U/D U D U/D
Signaling 39 44 0.9 58 38 1.5 52 34 1.5 60 35 1.7
Transport 30 30 1.0 31 36 0.9 36 32 1.1 35 35 1.0
Transcription 38 47 1.2 52 44 1.2 54 39 1.4 57 43 1.3
CA 9 12 0.8 14 8 1.8 14 8 1.8 15 9 1.7
TFs 18 14 1.3 17 22 0.8 18 18 1.0 20 18 1.1
RP 11 21 0.5 21 14 1.5 22 13 1.7 22 16 1.4
Translation 22 43 0.5 48 22 2.2 57 17 3.4 59 15 3.9
RPs 16 30 0.5 33 16 2.1 40 12 3.3 42 10 4.2
TLFs 6 13 0.5 15 6 2.5 17 5 3.4 17 5 3.4
Cytoskeleton 34 43 0.8 45 50 0.9 48 49 1.0 60 43 1.4
MPs 6 14 0.4 5 23 0.2 4 23 0.2 4 23 0.2
NMPs 28 29 1.0 40 27 1.5 44 26 1.7 56 20 2.8
ECM 24 12 2.0 30 7 4.3 28 8 3.5 28 11 2.5
Metabolism 39 53 1.4 48 76 1.7 45 76 0.6 59 74 0.8
CM 27 37 0.7 18 45 0.4 20 45 0.4 27 43 0.6
NCM 12 16 0.5 30 31 1.0 25 31 0.8 32 31 1.0
Protection 41 29 1.4 41 26 1.6 46 26 1.8 57 24 2.4
INF 23 10 2.3 18 13 1.4 18 14 1.3 25 12 2.1
APO 7 4 1.8 5 5 1.0 5 6 0.8 5 6 0.8
CHA 11 15 0.7 18 8 2.3 23 6 3.8 27 6 4.5
Degradation 28 28 1.0 30 26 1.2 32 25 1.3 39 24 1.6
PRO 11 15 0.7 9 13 0.7 15 13 1.2 17 11 1.5
NPRO 17 13 1.3 21 13 1.6 17 12 1.4 21 13 1.6
Cell cycle 20 25 0.8 21 27 0.8 27 23 1.2 37 17 2.2
G1/S 6 8 0.8 5 8 0.6 7 7 1.0 8 6 1.3
M 4 8 0.5 8 10 0.8 8 9 0.9 13 5 2.6
Other 10 9 1.1 8 9 0.9 12 7 1.7 16 6 2.7
CA= chromatin associated; TFs = transcription factors; RP = RNA processing;
RPs = ribosomal proteins; TLFs = translation factors; MPs =muscle proteins;
NMPs = non-muscle proteins; CM= carbohydrate metabolism; NCM=
non-carbohydrate metabolism; INF = inflammation; APO = apoptosis related;
CHA = chaperones; PRO = proteasome associated; NPRO= non-proteasome
associated.
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Figure S2). Comparison of Table 2 with Table 6 shows that
the overall U/D ratio was higher in Xenopus (1.3) than axo-
lotl (0.8). The three highest U/D ratios for Xenopus proteins
up or down regulated on all, or all but one time point were
for ECM (6.3), translation (3.1), and cell protection (1.9).
The three highest U/D ratios for the axolotl were for trans-
lation (4.7), ECM (2.0), and cell cycle (1.8). The lowest ra-
tios (<1.0) in both species were for cytoskeleton (due
primarily to depressed muscle proteins) and metabolism
(due primarily to depressed carbohydrate metabolism).The percentage of Xenopus proteins with FC =/>2 was
nearly 2.4 fold greater (33%) than the axolotl (14%) and
the maximum FCs were much higher in Xenopus, up to
32 FC, the majority of which were reached at 12 dpa. Of
the total of 1034 axolotl plus Xenopus proteins up or
down regulated at all dpa or 3 of 4 dpa, only 8.9% were
common to both species (Table 7). Table 8 lists the
shared proteins and those expressed in the axolotl but
not Xenopus. The highest percentages of shared proteins
were found in the categories of translation (18%) and
cytoskeleton (17.4%), followed by cell protection (9.5%),
metabolism (9.0%), degradation (8.9%), signaling (7.5%),
and ECM (7.4%). The least shared percentage of proteins
was in the categories of transcription (4.5%) and intra-
cellular transport (2.7%). Cell cycle was the only category
that had no shared proteins.
Signaling
The U/D ratio of this protein category was slightly higher
for Xenopus (1.6) than axolotl (1.3) (Tables 2 and 6). The
two species shared 7.5% of their signaling proteins
(Table 7).
IP3/DAG pathway and calcium translocation
Inositol triphosphate (IP3) and diacylglycerol (DAG) are
second messengers generated by G-protein and RTK recep-
tor signaling. In this pathway, inositol-3-phosphate synthase
(ISYNA1) catalyzes the synthesis of inositol from glucose-
6-phosphate. Inositol is converted to phosphatidylinositol-
4, 5 bisphosphate (PIP2), which is then cleaved by
phospholipase C (PLC) to IP3 and DAG. IP3 triggers Ca
2+
release from the endoplasmic and sarcoplasmic reticulum,
resulting in the translocation of protein kinase C (PKC) to
the plasma membrane, where DAG activates it to regulate
transcription [47]. Planarian regeneration has been shown
to be dependent on Ca2+ [48]. In the regenerating axolotl
limb, channel proteins in the plasma membrane that
mediate extracellular Ca2+ influx into the cytosol were
up regulated on all dpa (CACNA1A, ATP11A), or at 7
dpa (CACNA2D3), while proteins that translocate Ca2+
from the cytosol to the ER/SR (ATP2A3, SRL, ASPH), buf-
fer cytosolic Ca2+ during muscle contraction (PVALB), or
regulate transport of Ca2+ into and out of cells (CAMK2D)
were down regulated on all dpa or two of three dpa [45].
In addition to Ca2+, Na+ influx through sodium channels
is obligatory for newt limb regeneration [49] and H+ efflux
driven by a plasma membrane v-ATPase is obligatory for
regeneration of Xenopus tadpole tails [50].
Inositol phosphates are among the earliest signals asso-
ciated with urodele limb regeneration. They are generated
from PIP2 within 30 s after amputation of the newt limb
and inhibition of their formation by beryllium inhibits
blastema formation [51,52]. Consistent with these results,
we found that ISYNA1 was up regulated with FC >2 in
Figure 3 Validation of LC/MS/MS. Immunofluorescent antibody staining and mean densitometric sum for β1 integrin, vimentin, and
dystroglycan, comparing control, 5 dpa and 12 dpa sections of regenerating froglet hindlimbs. A-D, β1 integrin; E-H, vimentin; I-L, dystroglycan.
The 1, 5, 7 and 12 dpa fold changes for each of these proteins were: β1 integrin-1.05, 1.28, 2.18, 2.80; vimentin—1.07, 1.94, 2.30, 3.15;
dystroglycan-1.20, −1.40, −1.49, −2.02. The immunofluorescence and densitometry data thus agree well with the LC/MS/MS proteomic data.
Table 6 Number of axolotl proteins in each biological
process category that are up regulated (U) or down
regulated (D) on all dpa or 2 of 3 dpa, and U/D ratios
Biological process Total
Category Proteins U D U/D
Signaling 43 23 20 1.3
Transcription 58 26 25 1.0
Chromatin associated 14 8 5 1.6
Transcription factors 22 11 7 1.6
RNA processing 22 7 13 0.5
Translation 20 14 3 4.7
Ribosomal proteins 13 9 2 4.5
Translation factors 7 5 1 5.0
Cytoskeleton 64 14 48 0.3
Muscle proteins 24 0 23 0.0
Non-Muscle proteins 46 14 25 0.6
Extracellular matrix 19 12 6 2.0
Metabolism 33 9 23 0.4
Cell Protection 35 16 16 1.0
Inflammatory-Related 8 6 2 3.0
Apoptosis-Related 13 5 8 0.6
Chaperones 14 5 6 0.8
Degradation 12 4 4 1.0
Cell cycle 13 7 4 1.8
Total 125 149 0.8
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ISYNA1 was not detected in the froglet limb, and INPP5F,
a phosphatase that hydrolyzes PIP2, was down regulated,
suggestive of deficiencies in the IP3//DAG early signaling
pathway. Phospholipase C was up regulated in the froglet
limb with FC > 2 at 12 dpa, when the equivalent of an
accumulation blastema had been established. ATP2A3,
PVALB, and calsequesterin 1 were down regulated (theTable 7 Number of proteins common to blastema/
fibroblastema formation in regenerating axolotl and
Xenopus limbs
Biological process
Category Common Axo+/Xeno− Xeno+/Axo−
Signaling 10 (7.5) 35 87
Transport 2 (2.7) 6 68
Transcription 7 (4.5) 50 98
Translation 15 (18.0) 5 63
Cytoskeleton 25 (17.4) 41 78
Muscle 10 (25.6) 11 18
Non-Muscle 15 (14.3) 30 60
ECM 4 (7.4) 14 36
Metabolism 14 (9.0) 19 121
Cell protection 10 (9.5) 25 70
Degradation 5 (9.0) 6 50
Cell cycle 0 (0.0) 14 56
Total 92 (9.0) 215 (21.0) 727 (70.0)
Numbers in parentheses indicate percent shared.
Table 8 Proteins found in regenerating limbs of A.
mexicanum but not X. laevis and proteins shared by the
two species
Axo+/Xeno− Axo+/Xeno+
Signaling + APC YWHAE (−/+)
+ ARL1 YWHAZ (−/+)
+ CCDC88C GDI2 (NC/+)


























- DNAH3 PVALB (−/−)
+ DYNC1LI2 DYNLL1 (−/+)
NC ANXA4 ANXA1 (−/+)
- ASPH ANXA2 (−/+)
+ ATP11A ATP2A3 (−/−)
Intracellular transport + CACN1A CASQ1 (+/−)





Table 8 Proteins found in regenerating limbs of A.




+ Histone 2A H2AFY2 (+/+)
(H2AFX) (+/+)
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Table 8 Proteins found in regenerating limbs of A.












- SNRPD3 SNRPE (−/+)
-SRRM1 TARDBP (+/−)
Translation
Ribosomal proteins: + RPL31 RPL12 (+/+)










Translation factors: + PABPC1 EEF1A2 (+/+)
- TARSL2 EEF2 (+/+)
+ ETF1 EIF4A1 (+/NC)
EIF4B (+/+)
Cytoskeleton
Muscle proteins: - MYH3 ACTA1 (−/−)
- MYH4 ACTN3 (−/−)
- MYH7 DES (−/+ & -)
- MYH7B MYBPC3 (−/+)
- MYL2 MYH13 (−/−)
- MYL3 MYL1 (−/−)
- MYL5 MYLPF (−/−)
- NEB TNNC2 (−/−)
- OBSCN TNNT3A (−/−)
- TM7 TPM2 (−/−)
- TPM3
Non-Muscle proteins: - ACTBL2 ACTG1 (+/+)
- ACTN1 DESPLK (NC/+)
- ACTN4 DESPLK
Isoform II (−/+)
Table 8 Proteins found in regenerating limbs of A.
mexicanum but not X. laevis and proteins shared by the
two species (Continued)
+ ACTR2-A KRT12 (−/+)
+ EPPK1 KRT19 (+/+)
+ FLNB KRT5.5 (−/+)
- GOLGA1 PLS3 (−/+)
NC Myo9A EZR (+/+)
+ NAV1 TUBB2C (+/NC & +)
+ SYNE2 XAKB (−/− & +)
+ TUBA XAKC (−/+)
+ TUBA4B CytoKer II (−/+)
+ TUBB4
- DNAH3 MVP (−/+)

















+ Col12A1 FGB (+/+)
+ ColXIII1 FGG (+/+)
+ Col1A1 FN1 (+/+)
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Table 8 Proteins found in regenerating limbs of A.
mexicanum but not X. laevis and proteins shared by the
two species (Continued)
Metabolism
- ABCB10 ATP5B (−/NC)
- CS COX5A (−/+)
- ECHS1 GLUD1 (−/+)
- SLC25A13
- ALDOC ALDOA (−/−)
- ENO3 ALDOB (−/−)





+ ACACA AK1B (−/−)
+ ALDH6A1 B3GNT5 (+/−)





























Table 8 Proteins found in regenerating limbs of A.
mexicanum but not X. laevis and proteins shared by the
two species (Continued)
Chaperones: - HSP27 CCT2 (+/+)
+ HSP90AB2P FKBP10 (−/+)
+ HSPB3 HSP90AA1 (−/+)
- PCMT1 HSP90B1 (+/+)
+ SSR1 PDIA3 (−/+)
+ TOR1A PDIA6 (+/+)
























Bold indicates FC =/>2 on one or more dpa; + indicates up regulated; - indicates
predominantly down regulated during blastema/fibroblastema formation. NC
indicates no change. For the shared proteins, the first symbol(s) in parentheses
indicate axolotl, and the second symbol(s) indicate Xenopus.
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place from storage compartments in the amputated froglet
limb. In general, however, proteins involved in calcium
translocation were more predominant in the axolotl than
the froglet. The systematic under-expression of up regu-
lated and over-expression of down regulated ion-binding
proteins would be useful in dissecting the roles of the vari-
ous ion-binding proteins involved in blastema formation.
It is not known whether H+ efflux or Na+ influx is essen-
tial for limb regeneration in either Xenopus or axolotl.
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Annexins, calcium-dependent phospholipid binding pro-
teins with important signaling and other functions [53],
for review were detected in the regenerating limbs of
both axolotl and froglet. The axolotl expressed annexins
A1, 2, 4 and 6. With the exception of A2, which was up
regulated at 1 and 4 dpa, these showed either down
regulation or no change before being up regulated at 7 dpa.
None had FC =/>2. The froglet limb expressed annexins
A1, 2, 5, 6, 7, 8, and 11, and the ANAXA2 binding partner
S100A10A, but not annexin A4. All except A6 were up
regulated, with A1, 2, 8, and S100A10 showing FC =/>2 at
12 dpa. Annexin A6 was down regulated with FC <2 at all
time points in the froglet limb, whereas A5 was up regu-
lated with FC >2. A6 acts as a scaffold for recruiting PKC
to the cytoskeleton, and A5 is a negative regulator of PKC
activity, suggesting that although PKC expression is up
regulated at 12 dpa in the regenerating froglet limb, it may
not be recruited to the plasma membrane and/or its ac-
tivity is down regulated, again suggesting a potential defi-
ciency in the IP3/DAG pathway. By contrast, the axolotl
up regulates GNB2L1, a protein that anchors PKC to the
plasma membrane, and PKC rises to a peak at accumula-
tion blastema to medium bud [54]. Annexin A5 interacts
with type II collagen, an interaction that might play a role
in the deposition of ECM in the cartilage spike. Annexin
functions of potential importance to blastema formation
in both axolotl and froglet are the stimulation of osteoclast
formation and bone resorption (A2), and inhibition of en-
zymes involved in inflammation (A1, A2, A5) [29,55].
Annexins A4 and 6 promote exocytosis in epithelial cells,
which may be important for the phagocytosis and elimin-
ation of debris by wound epithelium during early blastema
formation [56]. Annexins and S100A10 are up regulated
in regeneration-competent stage 53 Xenopus limb buds as
well [44], indicating that their functions are similar in
blastema formation of both early tadpole and froglet. In-
creased expression of several S100 family Ca2+-binding
proteins has also been observed in the regenerating ear
tissue of MRL/Mpj-Fas mice compared to control C57BL/
6 J mice [57,58], suggesting that annexins play a role in
mammalian regeneration as well.
NOS1
Another aspect of signaling that differed in axolotl and
froglet limbs was the expression of neuronal nitric oxide
synthase (NOS1), which catalyzes the synthesis of nitric
oxide (NO), a gas that has many signaling functions
[59,60]. Grow [33] found that NOS1 transcripts were highly
up regulated in amputated stage 53 Xenopus limb buds but
not in amputated stage 57 limbs, suggesting that failure to
produce NO is a factor in the loss of regenerative compe-
tence as the Xenopus limb bud differentiates. NOS1 was
not detected in the froglet limb, confirming this suggestionat the protein level. NOS1 protein was highly up regulated
at 1 dpa in the axolotl limb, declining toward control level
by 7 dpa, and anti-NOS1 antibody staining showed that it
was confined to the wound epidermis. The high expression
of NOS1 in axolotl wound epidermis at 1 dpa suggests that
NO might activate proteases involved in histolysis [61] and
its absence in the Xenopus limb might indicate deficiencies
in histolysis associated with MMP production [62]. NO
might also stimulate axon and capillary regeneration, both
of which the accumulation blastema requires for growth.
Wnt pathway
The Wnt pathway has been implicated in the regener-
ation of deer antlers [63], zebrafish fin regeneration [64],
axolotl limb regeneration [65], and regeneration of limb
buds in Xenopus tadpoles [65]. Heat shock-induced ex-
pression of the canonical Wnt antagonist Dkk inhibited
blastema formation in transgenic Xenopus stage 53 limb
buds, which are not yet innervated [66], and epidermal-
mesenchymal interaction was disturbed by the forma-
tion of a thick basement membrane. Wnt3a transcripts
were detected in the epidermis of amputated adult Xenopus
limbs, but expression of Dkk had little effect on
epidermal-mesenchymal interactions unless the limbs
were denervated, suggesting that Wnt signaling and nerve
signaling have redundant roles in fibroblastema formation
[67], or that some nerve-dependent function of the epider-
mis has been compromised.
Wnt8a and APC, components of the canonical Wnt
pathway, were detected with FC > 2 and < 2, respect-
ively, during axolotl blastema formation. Inversin, a
component of the non-canonical pathway, was up regu-
lated with FC > 2. Inversin targets the Disheveled (DVL)
protein for degradation, switching the canonical path-
way to the non-canonical pathway [68]. The DVL-binding
protein, CCDC88C, a negative regulator of the canonical
pathway, was up regulated in the axolotl limb on all dpa,
and DIXDC1, a positive regulator of the canonical path-
way, was down regulated on all dpa. The presence of both
canonical and non-canonical Wnt pathway components
suggests that both pathways may be essential for blastema
formation in the axolotl limb [65].
No Wnt proteins were detected in our amputated froglet
limbs, but BRD7, which activates the canonical Wnt path-
way by Disheveled-dependent phosphorylation of GSK3B,
was down regulated in the froglet limb with FC > 2. These
patterns of protein expression suggest that Wnt signaling,
though perhaps not essential for abnormal blastema forma-
tion in the froglet limb, may be required for events that re-
sult in the formation of a regeneration-competent blastema.
Receptors and kinases
The expression of receptors and kinases was of interest
for signaling. In the axolotl limb, GPR109B, the receptor
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EPHA7, the receptor tyrosine kinase for the A1 to 5 mem-
bers of the ephrin A family of ligands was up regulated
with FC < 2. EPH and EPH-related receptors have been
implicated in neural development [69,70]. With regard to
kinases, TYK2, which phosphorylates receptors of the
JAK/STAT signaling pathway was up regulated during
axolotl blastema formation, whereas PTK6, which phos-
phorylates STAT proteins, was down regulated on all dpa.
In the froglet limb, the neural receptors NGFR, DLGH4,
GPR83.2 and GRIK2 were up regulated, while the neural
receptor GABBR2.2 was down regulated, all with FC > 2.
Moreover, RUFY3, a protein active in growth cones that
has been implicated in axon formation by developing
neurons was up regulated with FC > 2 at 7 and 12 dpa.
The strong expression of most of these neural receptors
conforms to the fact that, as in the axolotl, formation of the
froglet fibroblastema is nerve-dependent [21,22,71]. ROR2
and IGF-1R, two receptors involved in chondrocyte differ-
entiation, were up regulated with FC > 2 during fibroblas-
tema formation, perhaps reflecting its propensity for
cartilage differentiation. LMBR1 (limb forming region 1), a
lipocalin receptor that contains a shh DNA-binding domain
and is involved in retinoid transport, was up regulated in
the fibroblastema. Lastly, Rab family GTPases were up reg-
ulated in both axolotl and froglet limbs. This family of pro-
teins plays a critical role in vesicular recycling of receptors,
providing another means of regulating signaling.
In Xenopus, three kinases were up regulated at 12 dpa
with FC > 2, PIK3R4, MAPK1 and STK38. PIK3R4 is a
regulatory subunit of the phosphoinositide 3-kinase
complex (PI3K) that regulates other proteins through
PKB (AKT) and MAPK1 is an extracellular signal kinase
(ERK). ERKs phosphorylate transcription factors and are
the final step and integration point for Ras pathway
intracellular signaling cascades. STK38 (12 dpa) is a
negative regulator of MAP3K1/2 signaling. It converts
MAP3K2 from its phosphorylated form to its non-
phosphorylated form and inhibits autophosphorylation
of MAP3K2. Kinases down regulated in the froglet limb
were MAPK15 (5, 7, 12 dpa) an ERK that phosphorylates
transcription factors, and WDR34 (12dpa), which in-
hibits the signal transduction functions of MAP3K7 re-
quired for TGFβ, BMP, MKK/JNK, Toll-like and IL-1R
receptor signaling pathways.
The PI3K pathway phosphorylates and activates the
anti-apoptosis protein AKT, whereas MAPK1/2 (ERK1/2)
is the substrate for MEK1/2 kinase activity in RTK signal
transduction. Suzuki et al. [23] studied these pathways
in vitro and in vivo in amputated froglet limbs transgenic
for GFP under control of the prx1 enhancer, using the in-
hibitors LY294002, which inhibits the phosphorylation of
AKT by PI3K, and U0126, which inhibits the phosphoryl-
ation of ERK1/2 by MEK1/2. Activation of the prx1 gene isan early marker of blastema cells in amputated Xenopus
[22] and axolotl [24] limbs. In the absence of the inhibitors
both pathways are activated within the first 4 dpa, though
the ERK pathway is activated slightly later than the PI3K
pathway. Inhibition of both pathways repressed GFP ex-
pression, decreased the number of BrdU + and PH-H3+
cells, and inhibited cell cycle progression in the limb
stumps. Thus, although Ras signaling pathways are acti-
vated in amputated Xenopus limbs, they appear to be in-
sufficient for normal blastema formation.
Adaptor proteins
A subset of adapter proteins was detected in the forming
blastemas of both axolotl and froglet. The most prominent
adapters detected were members of the highly conserved
tyrosine 3-monooxygenase/tryptophan 5 monooxygenase
activation (14.3.3) family, which contains 7 isoforms. Via
binding to phosphoserine/threonine proteins these enzymes
integrate many cellular processes such as metabolism, pro-
tein trafficking, signal transduction, apoptosis and cell cycle
regulation. YWHAZ (zeta) and YWHAE (epsilon) were
down regulated with FC < 2 throughout blastema formation
in the axolotl limb. By contrast, YWHAZ and YWHAE
were up regulated in the Xenopus fibroblastema, YWHAZ
with FC > 2 at 12 dpa. Two other members of this family,
YWHAG and YWHAQ were also up regulated in Xenopus
with FC < 2. Other adapter proteins detected in the fibro-
blastema but not in the axolotl blastema were WASF4 and
PDLIMB, which were up regulated and down regulated, re-
spectively, with FC > 2.
Chordin
The last aspect of signaling to be considered here is the
patterning molecule chordin, which was strongly up reg-
ulated at 5, 7, and 12 dpa in regenerating froglet limbs,
but was not detected in the regenerating axolotl limb.
Chordin is an antagonist of BMP and is known to dorsa-
lize early vertebrate embryonic tissues by binding to ven-
tralizing BMPs and sequestering them in complexes so
they cannot interact with their receptors [72]. The up
regulation of chordin in the amputated Xenopus limb
may dorsalize the fibroblastema to create symmetry in
the DV axis, thus complementing the AP symmetry
caused by the lack of shh expression [36].
Transcription
The U/D ratio for transcription-related proteins in the
axolotl blastema was 1.0 (Table 6). The comparable num-
ber for the Xenopus fibroblastema was 1.4 and 3.1
(Table 2). Shared proteins were 4.5% (Table 7).
Chromatin associated proteins
The chromatin-associated proteins expressed during
Xenopus fibroblastema formation were primarily
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state of chromatin condensation and remodeling (alter-
ation of DNA-nucleosome topology). Four such pro-
teins were up regulated with FC > 2. BTBD17 (12 dpa) is
a transcriptional repressor whose in vivo function has
not been defined. HIST1H1D (12 dpa) is a linker his-
tone essential for chromatin condensation. The high
mobility group proteins HMGB2 (12 dpa) and HMGX
(12 dpa) are non-histone DNA binding proteins that fa-
cilitate cooperative interactions between cis-acting
proteins.
Five chromatin-associated proteins were down regulated
with FC > 2 in the fibroblastema. ACTL6A (12 dpa) is part
of a HAT complex that activates transcription by acetyl-
ation of histones H4 and H2A. NCOR1, which was down
regulated with FC > 4 at 12 dpa, mediates ligand inde-
pendent transcriptional repression of thyroid hormone
and RA receptors by promoting histone deacetylation and
chromatin condensation. SIN3B (1, 5 dpa) represses tran-
scription by serving as a scaffold to tether HDAC enzymes
and thus prevent histone deacetylation. LRB (7, 12 dpa) at-
taches chromatin to the nuclear envelope and helps main-
tain chromatin structure. POLR1A (1, 5, 7, 12 dpa) is the
large subunit of a DNA-dependent RNA polymerase; it
had a FC of −5.3 at 1 dpa and −14.36 at 12 dpa. RNA
polymerase was not detected in the axolotl.
Several H21 and H2A histones were detected during
blastema formation in the axolotl limb, most of which
were up regulated. Hairless (HR) in rat functions as a tran-
scriptional co-repressor for thyroid hormone and interacts
with histone deacetylases. Two proteins that regulate gene
expression by covalent modification of histone proteins,
MTA1 and nucleosome assembly NAP1L1-A, were up
regulated at all dpa and 4 and 7 dpa, respectively. The his-
tone lysine demethylase JMJD1B (KDM3B) was down reg-
ulated on all dpa with the highest FC of all the axolotl
proteins, negative 6.8 at 7 dpa. This enzyme specifically
demethylates Lys-9 of histone H3. Methylation of this
amino acid leads to transcriptional silencing; maintenance
or up regulation of KDM3B expression would counter
this. The fact that KDM3B is strongly down regulated in-
stead suggests that the genes it regulates are transcription-
ally silenced as part of the shift in transcriptional activity
leading to repression of genes associated with tissue differ-
entiation and the activation of progenitor cell and more
embryonic ECM genes [73-76].
Transcription factors
In the amputated axolotl limb, most of the 21 transcrip-
tion factors detected were up regulated at all three or
two of three time points. Several of these factors,
NR2C2, NFATC4, and SOX6 induce transcription of
specific sets of genes. NR2C2 is a nuclear receptor for
mineralocorticoids and glucocorticoids, NFATC4 plays arole in inducing cytokine gene expression in T- cells, and
Sox6 is required for neurogenic and skeletal regeneration.
Of these, only NR2C2 had FC > 2, suggesting that minera-
locorticoids and glucocorticoids play an important signa-
ling role in axolotl blastema formation.
Transcription factors with functions related to dedif-
ferentiation are of particular interest. During blastema
formation in the amputated axolotl limb transcripts for
many of these are up regulated, such as the AEC
markers dlx3 and sp9 [77,78], the myogenic inhibitor
msx1 [79], a major mediator of stem cell renewal Notch),
and germ-line specific PL1 and PL2 genes, hallmarks for
the acquisition of stemness that may function to stabilize
the genome by repressing movement of retrotransposons
[80]. Denervation and morpholino depletion of PL1 and
2 cause the down regulation of FGF8, suggesting that
these transcription factors are involved in establishing a
nerve-dependent progenitor state in axolotl limb cells
[80]. King et al. [32] noted the activation of genes for
several retrotransposons in the blastema and fibroblas-
tema of stage 52/53 limb buds and stage 57 Xenopus
limbs, respectively. One of these retrotransposons was
LINE1, which is activated in the amputated axolotl limb
as well [81].
A four-factor gene cocktail consisting of the pluripo-
tency factors Oct4 and Sox2 plus either Klf4 and c-Myc
(OSKM) or Nanog and Lin 28 (OSNL) converts human
fibroblasts to pluripotent iPSCs [82,83]. Furthermore,
the Sall4 gene, one of the few pluripotency genes to be
expressed in tissue stem cells, augments expression of
the “fantastic four” [84]. We found that LIN28 protein
was up regulated throughout blastema formation in the
axolotl [45]. Transcripts for c-Myc, Klf4, and Sox2 are
also up regulated during newt limb and lens regeneration
[85,86]. The axolotl expresses Nanog as a monomer that is
sufficient to regulate pluripotency in mammalian cells
[87], though its expression has not been reported in the
regenerating limb. These data are again consonant with a
shift in transcriptional activity during axolotl limb blas-
tema formation toward a progenitor cell pattern. Repro-
gramming of axolotl limb cells produces undifferentiated
progenitor cells that are not pluripotent, but except for fi-
broblasts are restricted to replacing their original cell type
[88]. How factors that restrict the reprogramming of axo-
lotl limb cells by pluripotency factors to progenitor cells
instead of iPSCs, and allow a subset of fibroblasts to trans-
differentiate into other cell types is unknown.
Transcripts for several pluripotency factors have been
investigated in amputated stage 52 vs. stage 57 Xenopus
limb buds and limbs [89-91]. Stage 52 blastemas did not
express Oct4 or Lin 28, but Sall4 and Sox2 were expressed.
Stage 57 fibroblastemas also expressed c-myc, Sox2 and
Sall4, but at lower levels. These results suggest that stage
57 fibroblastema cells are only partly reprogrammed
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genome lacks the Nanog gene [87]. We did not detect
any of these transcription factors in our Xenopus pro-
teomic data. However, we did detect changes in the ex-
pression of SALL1 (up regulated) and LHX9 (down
regulated) at FC < 2. SALL1 is a transcriptional repres-
sor that might be involved in inhibiting the expression
of differentiation genes. LHX9 is a LIM homeodomain
protein that with LHX1 and 2 integrates signaling
events linking limb patterning and outgrowth in all
three axes [92]. The down regulation of LHX9 might
contribute to the faulty patterning of the fibroblastema.
A number of other transcription factors with FC > 2
were detected in the Xenopus fibroblastema. PIAS4,
MEOX2, LRRFIP1, and TAF3 were up regulated at 12
dpa. TAF3 (TFIID) is one of the general transcription
factors required for transcriptional initiation by RNA
polymerase II. PIAS4 functions as an ezrin-type small
ubiquitin-like modifier (SUMO) ligase. It is a negative
regulator of transcription in the Wnt, STAT, p53 and
steroid hormone pathways. MEOX2 is a target gene of
the TGF-β pathway that regulates the development of
skeletal, cardiac and smooth muscle and may play a role
in the regulation of limb myogenesis. Since the Xenopus
regenerate does not possess muscle, MEOX2 might
regulate muscle repair in the stump region just proximal
to the fibroblastema, or regulate TGF-β-driven fibrosis.
LRRFIP1 is a transcriptional repressor for genes encoding
TNF, EGFR, and PDGFA, and controls smooth muscle
proliferation by repressing PDGFA after injury.
Other transcription factors up regulated were SNIP1
(7, 12 dpa), REST-A (5, 7, 12 dpa), FOXD5 (all dpa), and
FOX D5-B (all dpa). SNIP1 is a SMAD nuclear interact-
ing protein that inhibits BMP-induced gene responses
[93], which are important in limb development and regen-
eration [64,94], and thus may play an inhibitory role in the
formation of a normal blastema in the froglet limb. REST
A represses transcription of neuronal genes in non-neural
tissues and has been implicated in axon extension. FOXD5-
B plays a role in cartilage development and thus might
be essential for the chondrogenesis of spike formation.
FOXD5, FOXD5-B, and SNIP1 showed exceptional FCs
of 4.73, 4.79, and 6.8, respectively, at 12 dpa.
Several transcription factors were down regulated with
FC > 2 in the fibroblastema. NF7 (nuclear factor 7) (1
dpa) is a putative maternal transcription factor select-
ively retained in the cytoplasm from fertilization to mid-
blastula in Xenopus and functions in DV patterning. Its
down regulation may be another factor contributing to
the DV symmetry of the cartilage spike. CNOT10 (12
dpa) is a subunit of the CCR4-NOT transcriptional
regulation complex that is also an effector of mRNA
decay. E2F8 (12 dpa) directly represses a subset of E2F1-
dependent cell cycle progression genes. PAX1 (12 dpa) isa transcriptional activator belonging to the PAX family of
proteins that interacts with MEOX2 and plays an import-
ant role in vertebrate embryonic pattern formation.
SIX4.2 (5, 7, 12 dpa) has been implicated in otic, olfactory,
and optic neural cell differentiation. Down regulation of
these transcription factors potentially could have inhibi-
tory effects on fibroblastema pattern formation.
RNA processing proteins
The majority of the RNA processing proteins detected in
the amputated limbs of both species was heterogeneous
nuclear ribonuclear proteins, small nuclear riboproteins
and splicing factors. Most of the axolotl RNA processing
proteins had FC < 2 and were predominantly down regu-
lated (U/D, 0.5) until 7 dpa, when the U/D ratio flipped to
1.5 (Table 6). The only axolotl RNA processing proteins
with FC > 2 were CWC15, a component of the PRP19-
CDC5L complex that forms an integral part of the spliceo-
some, and the dead box protein DDX46; both were down
regulated. Dead box proteins are RNA helicases that con-
tribute to the regulation of differentiation by their ability
to modulate RNA secondary RNA structure, and thus
availability, in processes such as ribosome and spliceo-
some assembly, translation initiation and RNA splicing.
In the Xenopus fibroblastema, RNA processing proteins
were more highly up regulated (U/D ratio, 1.5) than in the
axolotl blastema (Tables 2 and 6). Several splicing and
dead-box proteins were up regulated by the fibroblastema.
Proteins up regulated with FC > 2 were BXDC5,
HNRNPH1, LOC494754, and LSM14A at 12 dpa. BXDC5
has been implicated in ribosome biogenesis. HNRNPH1
and LOC494754 are proteins that bind to heterogeneous
nuclear RNA and are involved in RNA splicing and me-
tabolism. LSM14A functions in the formation of P-bodies,
cytoplasmic structures that provide storage sites for non-
translating mRNAs. DDX18 and DDX54 were up regu-
lated at 12 dpa. DDX18 plays an important role in cell
proliferation and DDX54 represses the transcriptional acti-
vity of nuclear repressors. DDX21 was up regulated at 1
and 12 dpa. This is a nucleolar protein involved in the pro-
cessing of 20s rRNA to 18 s rRNA. LRPPRC (7, 12 dpa)
plays a role in the RNA metabolism of both nucleus and
mitochondrion. DDX39 was detected in the developing
limb buds of Xenopus from stages 48–55 [95], but did not
appear in our regenerating froglet limbs.
Four processing proteins were down regulated with
FC > 2. U2AF1 is down regulated at 5 and 12 dpa, and
CCNL2 (cyclin 2) at 7 and 12 dpa; both are splicing factors.
CCNL2 is a novel member of the cyclin family. Overexpres-
sion inhibits proliferation and differentiation of mouse EC
p19 cells and induces them to undergo apoptosis. RNPS1-
A and SCNM1 are down regulated at 5, 7, and 12 dpa.
SCNM1 functions as a splicing factor; RNPS1-A is part of
a post-splicing multiprotein complex that detects exported
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nonsense-mediated mRNA decay. The FC at 12 dpa for
RNPS1-A, CCNL2 and SCNM1 was very high, −5.76, −6.2,
and −10.18, respectively.
Translation
The U/D ratio for translation-related proteins was 4.7 in
the axolotl and 3.1 in Xenopus (Tables 2 and 6). Eighteen
percent of translation-related proteins were shared be-
tween axolotl and Xenopus (Table 7). A large number of
ribosomal proteins was detected in both axolotl and
Xenopus, many shared (Table 7). Most ribosomal protein
showed FC < 2 in both species. In the amputated axolotl
limb, two proteins, RPL7L1 and RPS20, were up regulated
with FC > 2. Factors for initiation (PABPC1), binding of
mRNA to the ribosome (E1F4B), and translocation of nas-
cent protein from the A site to the B site of the ribosome
(EEF2) were down regulated or unchanged at 1dpa in the
regenerating axolotl limb, but were up regulated at 4 and
7dpa. Another initiation factor, E1F4A1, was down regu-
lated at 1dpa, returned to control level at 4dpa, and was up
regulated at 7dpa. The elongation factor EEF1A2 was up
regulated on all dpa. TARSL2, which is involved in tRNA
aminoacylation, was up regulated at 1dpa, and down regu-
lated at 4 and 7dpa. Lastly, a translation termination factor,
ETF1, was up regulated at 4 and 7dpa. Three non-shared
transfer RNA ligases and one tRNA synthetase were up
regulated with FC > 2 in the Xenopus fibroblastema.
Cytoskeleton
Overall, cytoskeletal proteins were down regulated, but
less so in the Xenopus fibroblastema than the axolotl
blastema (U/D ratio, 0.9 vs 0.3) (Tables 2 and 6).
Non-muscle proteins
Non-muscle proteins were predominantly down regulated
in the axolotl limb (U/D ratio, 0.6), but up regulated in
the Xenopus limb (U/D ratio, 2.1). Fourteen percent of the
non-muscle cytoskeletal proteins were shared (Table 7).
Non-muscle cytoskeletal proteins included those involved
in adhesion, intracellular movement, motility, shape, cyto-
skeletal organization and cytoskeletal-associated kinase
signaling. They were predominantly up regulated in the
amputated Xenopus limb (U/D ratio, 2.1) and down regu-
lated in the amputated limb of the axolotl (U/D ratio, 0.6).
Seven of the non-muscle cytoskeletal proteins in the
axolotl had FC > 2, of which five were up regulated at one
or more dpa and two were down regulated. The five up
regulated proteins were NAV1 (7 dpa), PMFB1 (1, 7 dpa),
SYNE2 (7 dpa), MYO1E (1 dpa), and STE3GAL5 (1 dpa).
NAV 1 possesses 3' to 5' helicase activity and exonuclease
activity. The exact function of this protein is unknown,
but is thought to play a role in neuronal development and
regeneration. PMFB1 and SYNE2 are involved in thegeneral organization of the cytoskeleton that maintains
cytoskeletal spatial organization and cellular morphology.
ST3GAL5 catalyzes the synthesis of ganglioside GM3,
which participates in the maintenance of cellular morph-
ology, but also integrin-mediated cell adhesion. MYO1E is
a non-muscle class I myosin that may be involved in intra-
cellular movement and membrane trafficking. Down regu-
lated proteins were FHDC1 (all dpa) and SORBS1 (all
dpa). FHDC1 is involved in cytoskeletal organization and
SORBS1 is involved in forming actin stress fibers and focal
adhesions and is also required for glucose-stimulated insu-
lin transport. A number of keratins were expressed with
FC < 2. Keratin 12, keratin 5.5 (larval keratin), and keratin
XAK-C were down regulated at 1 and 4 dpa before being
up regulated at 7 dpa, keratin 19 was down regulated at 1
dpa and up regulated at 4 and 7 dpa, and keratin XAK-B
and keratin type II were down regulated at all time points.
In the amputated Xenopus limb, 33 proteins were up
regulated with FC >2. Thirteen of these were epithelial
keratins: KRT13, KRT19, KRT5.2, KRT6, XAK-A, XAK-
C, KRT 14, keratin-3, type I cytoskeletal 51 kDa, all up
regulated at 12 dpa; KRT15 (7, 12 dpa), keratin type II (7,
12 dpa), and two other intermediate filaments, vimentin
(VIM1) (7, 12 dpa) and MGC84118 (12 dpa). KRT14 was
the most highly up regulated with FC of 4.5. The
remaining highly up regulated Xenopus proteins are im-
plicated in actin binding or polymerization and adhe-
sion. PAFAHB1-B was the most highly up regulated of
these, 6.48 at 12dpa. This protein enhances dynein-
mediated microtubule sliding by targeting dynein to the
microtubule plus end. It may play a role in the migra-
tion of fibroblasts during wound healing and by extension,
in fibroblastema formation. Xenopus proteins involved in
functional or structural (cell junctions) adhesion were des-
moplakin (DSP) (12 dpa), integrin alpha chain V (ITGAV)
(12 dpa), NF2 (12 dpa), DSCAM (1, 5 dpa) and integrin
beta 1 (ITGB1) (7, 12 dpa). NF2 (neurofibromin) is similar
to the ezrin, radixin, moesin (ERM) family that is thought
to link cytoskeletal components to cell membrane proteins.
Ezrin itself was also up regulated, but by much less than 2.
The Xenopus non-muscle proteins down regulated were
EML1 (7, 12 dpa) and INTU (12 dpa), both involved in
microtubule assembly and organization and the ATP and
actin binding proteins FHOD1 (12 dpa), STK35 (5,7, 12
dpa), TMSB4X (12 dpa), GAP43 (5, 7, 12 dpa), TLN (12
dpa) and EPB4 (7 dpa). FHOD1 is required for assembly of
F-actin structures such as stress fibers and plays a role in
cell elongation by coordinating the organization of actin
fibers and microtubules. Talin and EBP4 are adhesion
proteins. Talin plays a significant role in assembling actin
filaments with integrins to link the cell membrane to
ECM constituents. TMSB4X (thymosin β4) binds to actin
monomers to prevent their polymerization, and is thus in-
volved in cell proliferation, migration, and differentiation.
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improves cardiomyocyte survival by stimulating produc-
tion of higher levels of the survival kinase PKB (Akt) and
is essential for the enhanced regeneration of Xenopus
limbs implanted with larval progenitor cells [96,97]. Down
regulation of thymosin β4 might thus impair limb cell
survival and dedifferentiation in Xenopus. GAP-43 is a
nervous system-specific membrane adaptor protein
that enables the association of phosphatidylinositol-4-
5 bisphosphate and PIP2 with actin to facilitate actin
polymerization. It is expressed at high levels in neur-
onal growth cones and is considered to be a crucial com-
ponent of an effective axon regenerative response. Its
down regulation suggests that the axon growth response
in the amputated Xenopus limb may be less than opti-
mal for effective neural-epidermal interaction.
Muscle proteins
Sarcomeric cytoskeletal proteins were heavily down reg-
ulated, with a U/D ratio of zero in the axolotl limb and
0.1 in the Xenopus limb (Tables 2 and 6). Nearly 26% of
the sarcomeric proteins of regenerating limbs are shared
by the two species (Table 7). In the axolotl, down regula-
tion of sarcomeric proteins on all or two of three dpa,
many with FC > 2, is consistent with evidence for the
cellularization of myofibers into mononucleate cells that
undergo dedifferentiation [52,98-100]. Recently, genetic
marking studies have indicated that muscle progenitor cells
in the axolotl limb blastema are derived solely from satellite
cells, not myofiber dedifferentiation, in contrast to the newt
limb, where they are derived solely by myofiber dedifferen-
tiation [101]. The negative FC in sarcomeric proteins is also
consistent, in both axolotl and Xenopus, with the simple
degradation of damaged muscle in a hypoxic environment.
Xenopus muscle harbors satellite cells, but the fibro-
blastema does not contain muscle-forming cells, even
though it is supportive of satellite cell differentiation into
muscle [102]. We do not know if myofibers in the am-
putated froglet limb undergo fragmentation and dediffe-
rentiation into mononuclear cells, as appears to happen
in urodeles. The source of the cells making up the fibro-
blastema (periosteum, dermal fibroblasts, Schwann cells,
or some combination is unclear. The extent of dedif-
ferentiation of the fibroblastema cells is also unclear.
Our histological observations, as well as those of others
[6,20], indicate that the cells of the fibroblastema have a
fibroblastic rather than mesenchymal morphology, and
that these cells begin differentiating into chondrocytes as
they accumulate under the wound epithelium.
Metabolism
Carbohydrate metabolism Recently, Shyh-Chang et al.
[103] found that reactivation of the Lin28a gene in a dox-
inducible Lin28a transgenic mouse enhanced epidermalhair regrowth, digit repair and ear tissue repair. This en-
hancement was correlated with up regulation of IDH3B,
SDHA, NDUFB3 and NDUFB8, enzymes involved in gly-
colysis and OxPhos, and was prevented by OxPhos inhib-
ition, suggesting that LIN28a enhances regeneration and
repair by up regulating glycolysis and OxPhos metabolic
reactions. Consistent with this idea, Gorsic et al. [104] de-
tected significant up regulation of the transcripts for cyto-
chromes b and c and intense antibody staining to these
cytochromes in the epidermis and underlying tissue of 4
dpa regenerating axolotl limbs. By extension, the LIN28
protein might promote blastema formation through a
similar up regulation of glycolysis and OxPhos enzymes
and thus ATP production.
Our proteomic data, however, are not consistent with
this idea. Carbohydrate metabolism was strongly down
regulated in both axolotl and Xenopus amputated limbs,
parallel with the down regulation of muscle cytoskeletal
proteins. The U/D ratio was 0.7 in the froglet limb and
0.4 in the axolotl limb. Several enzymes of the citric acid
cycle and OxPhos were detected in both the regenerating
axolotl and Xenopus limb, including ATP5a enzymes, and
COX-5a, but virtually all were down regulated throughout
blastema and fibroblastema formation. The OxPhos en-
zymes up regulated in the Lin28 transgenic mouse [103]
were not detected during blastema formation in the re-
generating axolotl limb, but were detected in Xenopus
where they were down regulated throughout fibroblas-
tema formation. Our data indicate that formation of both
the axolotl blastema and the froglet fibroblastema requires
the depression of glycolysis and OxPhos. This suggests
that if the function of LIN28 in axolotl blastema formation
is to reprogram cellular bioenergetics, such reprogram-
ming is the opposite of what is observed in mammalian
cells. Alternatively, or in addition, LIN28 may be involved
with other pluripotency transcription factors to silence
differentiation genes and activate genes characteristic of
progenitor cells, as outlined under.
Transcription factors The parallel down regulation of
muscle proteins and proteins involved in carbohydrate
metabolism is not surprising since muscle is the most
abundant and metabolically active tissue in the limb, and
carbohydrate metabolism would simply be reflecting the
damage to the muscle done by amputation. Reduced
carbohydrate metabolism is consistent with previous
studies on regenerating urodele limbs that showed a
marked decrease in O2 usage during formation of the
avascular blastema [105], for review, and the histochem-
ical absence of citric acid cycle enzymes [106,107], for
reviews. The up regulation of NOS1 in the regenerating
axolotl limb, particularly at 1dpa, might play a role in
metabolic depression, since NO inhibits glycolysis and
electron transport in skeletal muscle [108]. NOS1 was
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nection between depressed metabolism and blastema or
fibroblastema formation in amputated axolotl vs. Xenopus
limbs is an area worthy of future exploration.
Retinoid metabolism
One of the enzymes more strongly up regulated on all
dpa in the axolotl limb was DHRS4, which is involved in
the reversible reduction of all-trans and 9-cis-retinal.
This up regulation is consistent with the important roles
retinoids play, not only in metabolism, but also in the
patterning of the blastema [109,110]. In the amputated
Xenopus limb the retinol binding protein 3 (RBP3) was
up regulated with FC < 2 at 5 and 7 dpa. This protein
shuttles 11-cis and all-trans retinoids between the retinol
isomerase in the pigment epithelium and the visual pig-
ments in the photoreceptor cells of the retina; its func-
tion in the metabolism of fibroblastema formation is not
clear. RDHL, an oxidoreductase involved in RA synthesis
was up regulated in the froglet limb with FC > 2 at 12
dpa, suggesting that there is at least some RA synthesis.
Interestingly, McEwen et al. [111] found that the cellular
retinoic acid binding protein (CRABP2) and retinalde-
hyde dehydrogenase (RALDH), which catalyzes the for-
mation of RA from retinaldehyde, were up regulated in
amputated stage 52/53 limb buds, but no new RA survived
because the RA antagonist Cyp26b was also up regulated.
Iron metabolism
The iron-binding and transport molecule transferrin, which
is required for many metabolic reactions, was up regulated
at all time points in the Xenopus limb, though with FC < 2.
Transferrin is essential for mitosis in the axolotl blastema
[112]. We did not detect it during blastema formation in
the axolotl, but axolotl blastema cells do not exhibit sig-
nificant mitosis until the accumulation blastema has
formed and the AEC is fully innervated (8), whereas mi-
totic index is as high as 10% in the blastema at 3 dpa in
stage 52–53 limb buds [113].
ECM
The Xenopus and axolotl limbs shared 7.4% of the ECM
proteins expressed, primarily proteins of the plasma clot.
Of these, FGA/FGB (fibrinopeptide) and FGG (fibrino-
gen) were up regulated with FC > 2 at 1 dpa. The limbs
of both species up regulated fibronectin and matrilin 2
with FC < 2 and down regulated type II collagen coinci-
dent with up regulation of type I collagen. These
changes are indicative of a shift toward expression of a
less structured matrix. The axolotl limb also down regu-
lated collagen IV, a component of the basement mem-
brane of the wound epidermis, and collagen IV was not
detected in the Xenopus limb, consonant with observa-
tions indicating open communication between thewound epidermis and the underlying mesodermal tissues
in both species [1,114].
Two other Xenopus proteins up regulated with FC > 2
that may be relevant to regeneration were ALPL (tissue
non-specific alkaline phosphatase, 12 dpa) and TGFBI (12
dpa). ALPL may play a role in skeletal mineralization.
TGFBI (transforming growth factor beta-induced) is an
RGD-containing protein induced by TGF-β that binds to
collagens I, II and IV and inhibits cell adhesion. The U/D
ratio of ECM proteins was 2.0 for the amputated axolotl
limb and 6.0 for the amputated Xenopus limb. Since hist-
olysis plays a large role in blastema formation, this differ-
ential may suggest that the limb tissue matrix of the
Xenopus limb is more difficult to break down than that of
the axolotl limb.
Cell protection and protein degradation
The regenerating axolotl and Xenopus limbs share 9.5%
of the cell protection proteins they express.
Inflammation and Apoptosis
The amputated limbs of both axolotl and froglet up and
down regulated a variety of antimicrobial proteins that
defend against infection (Tables 2, and 6; Additional file
1: Table S1). The proteins most strongly down regulated
in both axolotl and Xenopus were members of the
CYP450 family involved in electron transport and drug
metabolism. The limbs of both species also up and down
regulate a balance of antioxidant and pro and anti-
inflammatory cytokines to minimize tissue damage due
to inflammation. In mammals, tissue macrophages pro-
duce many of these bactericidal proteins and inflamma-
tory/anti-inflammatory cytokines, and macrophages are
abundant throughout formation of the axolotl limb blas-
tema. Ablation of macrophages by clonodate during axo-
lotl blastema formation, but not during blastema growth
and differentiation, inhibited regeneration and induced
fibrosis [115]. Thus functioning macrophages appear to
be obligatory for blastema formation by virtue of a cyto-
kine contribution that prevents fibrosis, the opposite of
macrophage function in mammalian wound repair by
fibrosis.
The urodele regeneration blastema forms under avas-
cular and thus hypoxic conditions [99,116] that could
lead to apoptosis. Mammalian cells avoid hypoxia-
induced apoptosis by up regulating hypoxia induced fac-
tor 1A (HIF1a), which activates the PI3K-dependent cell
survival gene Akt, as well as glycolytic enzymes to main-
tain ATP production [117-120]. Neither HIF1a nor AKT
(aka protein kinase B) was detected in the amputated
limbs of either axolotl or Xenopus, but TUNEL assays
indicated little or no apoptosis in regenerating axolotl
limbs from 1 dpa on [121,122]. We detected a number
of pro- and anti-apoptotic proteins in both axolotl and
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which appears to dictate how much apoptosis occurs
and when. Extensive apoptosis occurs within the first
24 hr post-amputation in regenerating tadpole and
knifefish tails [123,124], and, like the presence of macro-
phages in the axolotl limb, is obligatory for regeneration
of the tadpole tail [123]. Investigations of apoptosis
within the first 24 hr post-amputation in the axolotl and
Xenopus limb have not been reported. The data on pro-
and anti-apoptotic proteins and macrophages suggests a
functional link between obligatory apoptosis and these
immune cells.
Unfolded protein response
Chaperones, such as heat-shock proteins and isomerases
mediate an unfolded protein response (UPR) to cell
stress caused by the accumulation of unfolded proteins
within the ER/SR. Such accumulation is due to loss of
Ca2+ homeostasis, inadequate disulfide bond formation
of nascent proteins, or deficient protein glycosylation
[47,125,126], for reviews. The UPR reduces the amount
of protein translocated into the lumen, increasing pro-
tein degradation by proteasomes and exocytotic mecha-
nisms, and increasing the capacity to accelerate protein
folding in the ER by up regulating isomerases and chap-
erones. Failure to refold mis-folded proteins or remove
them from the ER results in apoptosis. In the axolotl
limb 10 chaperones were detected that accelerate protein
folding in the endoplasmic reticulum. Five of these were
the heat shock proteins HSPB3, HSP90B1, HSP90AB2P,
HSP27, and HSP9AA1. HSPB90AB2P, HSP90B1, and
HSPB3 were up regulated with FC < 2, while the other
two heat shock proteins were down regulated. Expres-
sion of HSP70 transcripts was also detected in the re-
generating axolotl limb [127].
The UPR appeared to be stronger in Xenopus than
axolotl, because the U/D ratio for chaperones is 3.6 in
the former compared to 0.8 in the latter. Transcripts for
stress-response proteins, particularly HSP60 and HSP90,
were over-expressed in both amputated stage 52 limb
buds and regeneration-deficient stage 57 limbs [34]. HSP60
is a chaperone involved in the folding and assembly of
polypeptides into protein complexes in mitochondria.
Thus formation of both the canonical urodele-style
blastema and the Xenopus fibroblastema appear to re-
quire activation of a UPR. Proteins that remain mis-
folded are degraded by the ubiquitin-proteasome system,
as well as by various proteases. Nine percent of degrada-
tive proteins are shared between the two species.
Endocannabinoid
The amputated axolotl limb up regulated DAGLB on all
dpa with FC > 2. DAGLB catalyzes the conversion of
DAG to 2-AG. This endocannabinoid is required foraxonal growth during development and thus may play a
role in nerve regeneration but its up regulation is also
consistent with previous studies showing an increase in
endorphins after amputation of adult newt limbs, sug-
gesting its involvement in pain control during blastema
formation [128-130]. DAGLB was not detected in the
Xenopus limb.
Cell cycle
The U/D ratio of cell cycle proteins was 1.8 in the axo-
lotl and 1.2 in the froglet.
Xenopus
Several Xenopus DNA replication and repair proteins
were up regulated. RNASEH 2A (12 dpa) is a ribonucle-
ase that participates in DNA replication by mediating re-
moval of lagging strand Okazaki fragment RNA primers.
Other up regulated proteins that target DNA replication
and repair were SUMO2 (12 dpa), UBE2N (12 dpa), and
WDHD1 (12 dpa).
Xenopus cell cycle progression proteins up regulated
with FC >2 were CDC25-1-A (1, 12 dpa), TBRG1 (12
dpa), and TP53BP2 (5, 7, 12 dpa). CDC25-1-A is re-
quired for progression from G1 to S by activating cyclin-
dependent kinase CDKC2. It is specifically degraded in
response to DNA damage to prevent cells with chromo-
somal abnormalities from progressing through division.
TBRG1 and TP53BP2 (tumor protein p53 binding pro-
tein 2) impede cell cycle progression at G1 and G2/M,
respectively, in response to DNA damage. A central
function of TP53BP2 is to impede cell cycle progression
at G2/M and stimulate apoptosis by enhancing the DNA
binding and transactivation function of p53 on the pro-
moters of genes involved in these processes. After show-
ing no change in level at 1 dpa, TP53BP2 levels rose to
4.0, 5.2, and 14.0 at 5, 7, and 12 dpa, suggesting a strong
activation of p53.
Up regulated Xenopus proteins required for mitosis were
ANIN (7, 12 dpa; cytokinesis), NUMA1 (5, 7 dpa; forma-
tion and maintenance of mitotic spindles), PAFAH1B-1B
(5, 7, 12 dpa; establishment of mitotic spindle orientation),
the helicase RECQL4 (12 dpa; recombination), SASS6
(centrosome duplication), and STAG2 (5, 7 dpa; cohesion
of sister chromatids).
Other elements involved in Xenopus DNA replication/
repair and mitosis were strongly down regulated. The
DNA ligase LIG1 (12 dpa), the homologous recombin-
ation protein SMC6 (5, 12 dpa), the G1/S checkpoint
protein NBN (all dpa); CHEK1 (5, 7, 12 dpa), which me-
diates G2/M cell cycle arrest in response to DNA dam-
age; and RAD52 (all dpa) and ZMCM6A (12 dpa), two
components of the MCM helicase complex that initiates
DNA replication, showed strong down regulation, as did
the M-phase proteins NEK6 (required for chromosome
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and Rac GTPase activating protein, a part of the central-
spindlin complex that signals contractile ring formation
during cytokinesis.
Axolotl
Many fewer cell cycle proteins were detected during
blastema formation in the axolotl than in Xenopus [45].
Five proteins were up regulated on all dpa with FC < 2.
These were NME1, a kinase that facilitates the synthesis
of nucleoside triphosphates other than ATP, CROCC
and NDEL1, proteins contributing to centrosome cohe-
sion and anchoring microtubules to the centrosome, re-
spectively, TTN (titin), a structural molecule for
chromosomes, and ULA1 (beta amyloid precursor pro-
tein), which forms a heterodimer with UBE1C that can
bind and activate NEDD8, an ubiquitin-like protein re-
quired for progression through the G2 checkpoint. Sev-
eral axolotl cell cycle progression proteins were down
regulated at all or two of three dpa with FC < 2. Three of
these are involved in regulation of microtubule assembly.
MAP/Microtubule Affinity Regulating Kinase (MARK4)
regulates the transition between stable and unstable mi-
crotubules; XMAP215 is a microtubule polymerase that
organizes mitotic spindle poles; and Ras-related nuclear
protein (RAN) regulates microtubule polymerization
during mitosis. The others are the WD Repeat Domain
35 protein (WDR36), which is involved in cell cycle
progression; LOH11CR2A, the tumor suppressor and
negative cell cycle regulator; FUS, which promotes ATP-
independent annealing of complementary single-strand
DNAs; PPP1CC, which is a component of the PTW/PP1
phosphatase complex that plays a role in the control of
chromatin structure and cell cycle progression from mi-
tosis into interphase, and MMCM3, which is required for
DNA replication.
The tumor suppressor protein p53 is activated in the
axolotl limb following DNA damage by irradiation or an
alkylating agent [131]. The activity of p53 decreases dur-
ing blastema formation in the axolotl limb, and this de-
crease is obligatory for blastema formation [132].
Neither TP53BP2 nor p53 was detected in our prote-
omic screen of blastema formation in the axolotl limb,
consistent with the necessity for decrease in p53 activity.
The difference in TP53BP2 and p53 activity in regener-
ating axolotl limbs should be explored by targeted prote-
omic methods and transcript analysis.
MCM helicase complex
The picture that emerges from these data is one in which
both the axolotl and Xenopus up regulate some proteins
involved in DNA replication and repair, and cell cycle pro-
gression, and down regulate others. The proteins involved,
however, were totally different in the two species. Cellcycle was the only biological process category in which
there were no shared proteins. Nevertheless, one similarity
between the two species is that the RAD52 and ZMCM6A
proteins in Xenopus and the axolotl protein MMCM3 are
each part of the MCM helicase complex that initiates
DNA replication, and all were down regulated at all dpa.
The down regulation of MCM helicase complex proteins
in both Xenopus and axolotl is puzzling, given the import-
ance of this complex in initiating DNA replication and the
fact that both axolotl blastema and Xenopus fibroblastema
cells synthesize DNA [23,133,134]. Both species might rely
on alternative replication initiators, but then the question
is why should this be so? Moreover, there was another cell
cycle protein detected during blastema formation in the
axolotl that deepens the mystery of how cell cycle regula-
tion contributes to blastema formation [45].
EVI5
A cell cycle protein strongly up regulated with FC > 2 on
all dpa during blastema formation in the axolotl limb,
but not in the Xenopus limb, was the ecotropic viral in-
tegration factor 5 (EVI5), which acts to prevent prema-
ture progression through the G2/M boundary by
stabilizing EMI1, a protein that accumulates in the nu-
cleus in late G1 and inhibits cyclin A degradation by the
anaphase-promoting complex/cyclosome (APC/C) [135].
EVI5 may also play a role in the Hippo pathway, which
plays a role in the cell cycle, and cell differentiation and
dedifferentiation [136]. Vesicle trafficking regulates the
Hippo pathway by controlling the translocation of phos-
phorylated Yes-Associated Protein (YAP) from the cyto-
sol to the nucleus where YAP acts as a co-activator of
Smad-7 to activate cell cycle genes [137]. EVI5 inhibits
the trafficking protein Rab 11 [138,139], which could
prevent phosphorylated YAP from localizing to the nu-
cleus and acting as a mitotic signal. The EVI5/EMI1
complex is degraded after phosphorylation by Polo-like
kinase 1 (PLK1), allowing the cell to enter M. A trun-
cated version of EVI5 becomes associated with the
chromosomal passenger complex (CPC), and is essential
for cytokinesis [140]. Another protein that stabilizes
EMI1 is the prolyl isomerase PIN1, isolated from Xen-
opus [141], but we did not detect this protein or EMI1in
either axolotl or Xenopus. EVI5 up regulation has also
been demonstrated in the cells of the ring blastema that
regenerates ear tissue of the LPR/Mpj mouse lost by
punch biopsy [142].
During blastema formation in the axolotl limb dedif-
ferentiated cells and resident stem cells enter the cell
cycle, but have a very low mitotic index [143]. High
levels of EVI5 might delay the mitosis of blastema cells
until the system is certain that all necessary DNA repairs
are made prior to mitosis. Alternatively, or in addition
to this possibility, the G2 arrest afforded by high levels
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ferentiation and/or to reinnervation of the AEC. A
period of G2 arrest would insure that the maximum de-
gree of dedifferentiation is sufficient to form the accu-
mulation blastema. In the axolotl and newt blastema the
AEC becomes innervated and the blastema vascularized
by this stage, establishing the conditions necessary for
growth of the blastema by mitosis. Under the influence
of a signal from nerve axons the AEC produces a mito-
gen, the anterior gradient protein (AGP) that releases
blastema cells from G2 arrest, causing a dramatic in-
crease in the mitotic index [6]. AGP would bind to its
receptor PROD1 on the blastema cell surface, triggering
the activation of Polo-like kinase 1 to degrade EVI5/
EMI1 and allow entry into M phase.
BrdU and phospho-histone H3 labeling studies have
shown both DNA synthesis and mitotic cells in sections of
regenerating Xenopus limbs 1–4 days post-amputation at
a ratio of 300 (BrdU)/30 (phospho-H3) cells per section
[23], but mitotic indices for the various phases of Xenopus
limb regeneration have not been determined. Moreover,
we do not know whether AGP is expressed under the
influence of the nerve in amputated froglet limbs, or
whether it is a factor in the outgrowth of the fibroblas-
tema. The comparative analysis of the role of the neural/
epidermal circuit, AGP and other mitogens, cell cycle fac-
tors such as EVI5, PIN1, the chromosomal passenger
complex (CPC) and other molecular pathways affecting
mitosis [45,142] offer a rich opportunity to examine the
relationship of the cell cycle to epigenetic reprogramming
in the regenerating Xenopus froglet and axolotl limb.Conclusions
Some major similarities and differences between blastema
and fibroblastema formation emerged from the data that
call for more focused analysis.Similarities
Rab GTPases were up regulated in both axolotl and
Xenopus, supporting their importance in signaling path-
ways. Proteins involved in translation, particularly ribo-
somal proteins, were up regulated, consistent with the
need to translate whatever mRNAs are coding for pro-
teins involved in blastema and fibroblastema formation.
Four proteins involved in retinoid synthetic pathways,
DHRS4 (axolotl), and the LMBR1 receptor, RBP3 and
RDHL (Xenopus) were all up regulated, suggesting that
retinoid synthesis takes place during both blastema and
fibroblastema formation. Most significantly, muscle pro-
teins and enzymes involved in carbohydrate metabolism
were strongly down regulated in parallel, consistent
with muscle being the most metabolically active tissue
in the limb.Differences
There were several proteomic differences between the
axolotl blastema and Xenopus fibroblastema associated
with early signaling events, histolysis and dedifferentiation,
innervation, cell cycle, chondrogenesis, and patterning
that might help explain the poor blastema formation and
hypomorphic regeneration of the Xenopus limb compared
to the axolotl limb.
a. Early signaling
The very early production of IP3 and DAG from IP2,
and the Ca2+-driven translocation of PKC to the
plasma membrane in the amputated axolotl limb are
obligatory for blastema formation, but ISNAY1, the
enzyme which synthesizes inositol from glucose-6-
phosphate and is up regulated in the axolotl limb, is
not detected in the Xenopus limb. Furthermore,
annexin A6, which acts as a scaffold to recruit PKC
to the plasma membrane, is down regulated in Xen-
opus, while annexin A5, a negative regulator of PKC
activity is up regulated. These results suggest a defi-
ciency in Xenopus IP3/DAG second messengers that
would compromise downstream regulatory pathways
acting on histolysis and dedifferentiation or the acti-
vation of stem cells. Since these signals are among
the earliest known in amputated limbs, their disturb-
ance would have pleiotropic effects. Furthermore,
NOS1, which catalyzes formation of the versatile sig-
naling molecule NO, which is highly up regulated in
the axolotl limb, was absent in the Xenopus limb.
Lastly, Wnt signaling, which is clearly operative in
the axolotl limb, appears to be deficient in the Xen-
opus limb, since PIAS4, a negative regulator of Wnt,
is strongly up regulated.
b. Histolysis and dedifferentiation
Both axolotl and Xenopus limbs up regulated
annexin A2, indicating a remodeling of the limb
matrix, and both up regulated ECM proteins such as
fibronectin, matrilin 2, and collagen I while down
regulating collagen II, suggesting a less structured
matrix. There was mild up regulation of MMP 7 and
9 in Xenopus. However, the U/D ratio of ECM
proteins was 6.0 in Xenopus, as opposed to 2.0 in
the axolotl, suggesting a more complex and
potentially more difficult matrix in the Xenopus limb
to break down by proteolytic enzymes.
Although MMPs are active in the amputated limbs
of both axolotl and Xenopus, and chromatin-
associated proteins appear to be transcriptional si-
lencers in both, histological studies suggest that the
Xenopus blastema is formed primarily by the migra-
tion of fibroblasts activated in the periosteum of the
amputated skeletal elements, rather than by histo-
lytic liberation of cells and their dedifferentiation.
Rao et al. BMC Developmental Biology 2014, 14:32 Page 21 of 27
http://www.biomedcentral.com/1471-213X/14/32This view is consonant with our histological obser-
vations and the fact that PAFAHB1-B, a protein that
in mammals stimulates fibroblast migration during
wound repair was highly up regulated. A low degree
of dedifferentiation in Xenopus is also suggested by
the up regulation of non-muscle cytoskeletal pro-
teins (U/D ratio 2.1) as opposed to down regulation
in the axolotl (U/D ratio 0.6).
In mammals, LIN 28 appears to stimulate
bioenergetic reprogramming by up regulating
enzymes involved in aerobic metabolism. LIN 28 is
up regulated in the amputated axolotl limb, but was
not detected in the Xenopus limb. If LIN 28
promotes bioenergetic reprogramming in the axolotl
limb, the reprogramming is the opposite of what
occurs in mammals, because all components of
carbohydrate metabolism were strongly down
regulated. LIN 28 more likely collaborates in the
axolotl with the pluripotency factors OCT4, KLF4,
c-MYC, Sox2, and Sall4 to reprogram limb cells to
lineage-restricted progenitor cells. The repro-
grammed cells are likely to be fibroblasts, given the
recent evidence against myofiber dedifferentiation in
the axolotl. Although some pluripotency factors are
expressed in the amputated Xenopus limb, they seem
unable to stimulate the same level of fibroblast de-
differentiation that takes place in the axolotl limb.
Instead the fibroblasts simply migrate to form a
fibroblastema that differentiates into cartilage. Satel-
lite cells do not contribute to the blastema. Both
Xenopus and the newt appear to share a mechanism
that inhibits the migration of satellite cells into the
fibroblastema (Xenopus) and blastema (newt), but
this mechanism is part of a regeneration-competent
process in the newt and a regeneration-deficient
process in Xenopus.Reinnervation of the blastema/fibroblastema and the cell
cycle
EVI5 is strongly up regulated during blastema formation
in the axolotl limb, but was not detected in the regener-
ating Xenopus limb, suggesting a normal G2 pause for
proliferating cells. Neural receptors were up regulated in
Xenopus, but GAP-43 (growth associated protein), a
major component of motile growth cones that plays a
role in the induction of axonal and dendritic filopodia, is
strongly down regulated. GAP-43 is a crucial component
of an effective neural regenerative response; its down
regulation may compromise proper reinnervation of the
AEC and its signaling functions. In turn, sustained
growth of the fibroblastema may be compromised, lead-
ing to premature chondrogenesis, a notion congruent
with the strong up regulation of the receptors ROR2 and
IGF-1R and the transcription factor Fox D5-B, all ofwhich stimulate chondrocyte differentiation. The rela-
tionship of innervation, production of AEC signals such
as AGP and FGFs, the cell cycle and chondrogenic dif-
ferentiation is a prime target for comparative analysis of
blastema/fibroblastema formation and growth that can
be extended to other comparative models as well.Patterning signals
Four proteins involved in dorsoventral axial patterning
were detected in the Xenopus limb and warrant further
experimental analysis, two of which were up regulated
and two down regulated. The up regulated proteins were
chordin and SNIP1. Chordin is a signaling molecule that
dorsalizes the early Xenopus embryo by antagonizing
BMPs. SNIP1 is a transcription factor that inhibits BMP-
induced gene responses. The proteins down regulated
were NF7 and LHX9. NF7 (nuclear factor 7) is a mater-
nal transcription factor that determines the DV axial pat-
tern of the Xenopus egg and embryo. LHX9 is a LIM
family transcription factor that, along with LHX2 and
LMX1b, integrates the signaling events that link limb
patterning and outgrowth along all three axes. Collect-
ively, the data suggest that the expression patterns of
these proteins collaborate to dorsalize the fibroblastema,
to give the spike dorsoventral symmetry as well as an-
teroposterior symmetry.Methods
Animal surgery and tissue collection
All surgical procedures and animal care were carried out
according to the Association for Assessment and Ac-
creditation of Laboratory Animal Care (AALAC) stan-
dards followed at Indiana University-Purdue University
Indianapolis (IUPUI). Xenopus laevis froglets (1–1.5 cm
nose-cloacal length) were obtained from Xenopus 1, Inc
(Dexter, MI, USA). And allowed to acclimate to labora-
tory conditions for 1–2 weeks. Froglets were anaesthe-
tized in 0.0024% (wt/vol) benzocaine and hind limbs
were amputated unilaterally through the mid-tibia/fibula.
The tissue removed distal to the amputation site served
as the 0-day control. The regenerative tissue, along with
a sliver (approximately 1 mm) of stump tissue, was col-
lected post-amputation at 1 day (epidermal wound clos-
ure), 5 and 7 days (histolysis and dedifferentiation) and
12 days (accumulation fibroblastema). This time frame,
ending with a distal accumulation of fibroblastema cells,
is equivalent to the 1, 4, and 7 day post-amputation time
points ending in formation of an accumulation blastema
that were analyzed for the axolotl hindlimb [45]. The tis-
sues were rinsed in sterile phosphate buffered saline
(PBS) and flash frozen for LC/MS/MS proteomic ana-
lysis, which was conducted by Monarch Life Sciences
(Indianapolis, IN, USA).
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Limb tissues were treated as described previously [45].
In brief, they were fixed in Bouin's solution for 48 h be-
fore washing in 50% alcohol to remove the picric acid.
They were then decalcified for 3 weeks in Calci-Clear
(National Diagnostics, Atlanta, GA, USA) at room
temperature. The limbs were dehydrated in a graded
series of alcohols up to 100% (1 hr each), followed by
two changes of Histoclear (Fisher Scientific, Houston)
for 1 h each. They were then infiltrated overnight with
Pararaplast (Fisher Healthcare, A Fisher Scientific
Company, Houston, TX, USA), followed by a second
overnight infiltration with fresh paraplast. After embedding
in a third change of Paraplast, longitudinal sections were
cut at 10 μm, processed for staining with hematoxylin
and eosin or Mallory’s trichrome, and photographed at
10 × magnification on a Leica microscope.
Proteomic analysis
Sample preparation
Five pools of tissue were harvested from each of the con-
trol, 1 dpa, 5 dpa, 7 dpa and 12 dpa limbs. Each pool con-
tained six tissues, one from each hind limb of an individual
animal. The samples were processed as described previ-
ously [45]. In brief, flash-frozen tissues were homogenized
in lysis buffer containing 8 M urea and 10 mM dithiothrei-
tol (DTT). The resulting tissue homogenates were further
reduced by triethylphosphine, alkylated by iododethanol
and digested by trypsin overnight [144]. The peptide con-
centration in each pool was determinded by Bicinchoninic
Acid (BCA) Protein Assay (Bio-Rad, Hercules, CA, USA).
LC-MS/MS peptide separation
Tryptic digested peptides were analyzed by liquid
chromatography- mass spectrometry (LC-MS) as previ-
ously described [45]. Twenty μg of digested peptides from
each pooled sample was injected in duplicate onto a zorbax
300SB-C18 reverse column (1 mm× 5 cm) in a random
order and were run on a Surveyor high performance liquid
chromatography (HPLC) system (Thermo-Fisher Scien-
tific). The equipment configuration was maintained identi-
cal while performing the injections and data collection.
Peptides were eluted with a gradient from 5% to 45% aceto-
nitrile developed over 120 min at a flow rate of 50 μl/min,
and effluent was electrosprayed into the linear ion-trap
LTQ mass spectrometer (Thermo-Fisher Scientific). Data
were collected in the 'Triple-Play' mode (MS scan, zoom
scan, and MS/MS scan). The resulting data were filtered (to
increase the signal to noise ratio) and analyzed by a propri-
etary algorithm developed by Higgs et al. [145].
Protein identification
Using SEQUEST (Thermo-Fisher Scientific, Waltham,
MA, USA) and X! Tandem (an open source algorithmprovided by The Global Proteome Machine Organization
http://www.thegpm.org) database search algorithms, data-
base searches against non-redundant (NR) National Cen-
ter for Biotechnology Information (NCBI) Xenopus
database (updated in September 2007) were performed for
peptide sequence identification. A confidence score was
assigned to each peptide by q value (false discovery rate).
The score was based on a random forest recursive parti-
tion supervised learning algorithm. The percentage ID
confidence score was calibrated so that approximately X%
of the peptides with percentage ID confidence > X% were
correctly identified [146].
Proteins were classified according to their peptide
identification quality (priority). This priority system as-
signs identified proteins into four priority groups, as de-
scribed previously by Higgs [145]: Group 1 (P1),
multiple unique peptide sequences and at least one pep-
tide with >90% (q-value = 0.10) peptide identification con-
fidence; Group 2 (P2), single peptide with >90% peptide
identification confidence; Group 3 (P3), multiple unique
peptide sequences and at least one peptide with peptide
identification confidence between 75%-90%; Group 4 (P4),
single peptide with peptide identification confidence be-
tween 75%-90%. All peptides with confidence less than
75% were filtered out and discarded. Thus, P1 proteins
had the highest likelihood of correct identification and P4
proteins the lowest likelihood of correct identification.
Protein quantification and statistical analysis
Protein quantification was carried out using a non-gel
based and label-free proprietary protein quantification
technology described previously [145,146]. All measure-
ments on experimental samples reflect up- or down-
regulation, or no change, relative to zero day (freshly
amputated control tissue) samples. Every peptide quanti-
fied had an intensity measurement for every sample.
This measurement is a relative quantity giving the area-
under-the-curve (AUC) from the extracted ion chro-
matogram (XIC) after background noise removal. The
AUC was measured at the same retention time window
(1-min) for each sample after the sample chromatograms
had been aligned. The intensities were then transformed
to the log base 2 scale for reasons described previously
[45]. After log transformation the data were quantile nor-
malized [147]. This normalization removed trends intro-
duced by sample handling, sample preparation, HPLC,
mass spectrometry, and possible total protein differences.
If multiple peptides had the same protein identifica-
tion, their quantile normalized log base 2 intensities
were weight averaged proportionally to their relative
peptide ID confidences. The log base 2 protein inten-
sities were then fitted for each protein by a separate
ANOVA statistical. Finally, the inverse log base 2 of each
sample mean was calculated to determine the fold change
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FC was also given for each priority level. FC was com-
puted as mean regeneration group/mean control group. A
FC of 1 means no change.
The number of proteins with significant changes for
each priority group was calculated. The threshold for
significance was set to control the false discovery rate
(FDR) for each two-group comparison at 5%. The FDR
was estimated by the q value, as stated previously. Thus
protein fold changes with a q value less than or equal to
0.05 were declared to be significant, leaving 5% of the
determined changes assumed to be false positives.
We calculated the median percentage of coefficient of
variance (%CV) for each priority group. Percentage CV
values were derived from the standard deviation divided
by the mean on a percentage scale. The percentage CV
was calculated for replicate variation (technical vari-
ation) and the combined replicate plus sample variation.
In constructing biological process categories, only pro-
teins having peptide confidence levels of 90% and above
and with FDR < 0.05 were included. Many proteins were
identified either by the same sequences or different se-
quences in priority 1 or 2 or both. To avoid redundancy,
the fold changes of priority 1 were used if a protein was
present in both the priorities, and average fold change
was calculated if it belonged to same priority. If a pro-
tein had conflicting expression patterns (up-regulated in
one case, but down-regulated in the other) then it was
not considered.
Bioinformatic analysis
Proteins not recognized by the algorithm were manually
curated. NCBI blastp [148] was used to match the se-
quences of hypothetical/novel/unknown/unnamed/Locus
(LOC)/NIH Mammalian Gene Collection (MGC) proteins
against the 'vertebrata' category in blast (taxid: 7742) to
identify their closest neighbors. Only the proteins having
90% peptide ID confidence and with FDR < 0.05 were
chosen. Accession numbers, gene names and names of the
proteins were obtained from Uniprot or NCBI using the
protein IDs obtained in the raw data. GeneCards [149]
and Uniprot [150] were used to determine their biological
processes. Human Protein Reference Database (HPRD)
was used to determine molecular function and primary
cellular localization. Cluster 3.0 [151] and Java Treeview
[152] software available from Stanford University were
used to generate the global intensity expression maps
and protein interaction maps were obtained using Bio-
Grid (http://thebiogrid.org/). The images were drawn
using CIRCOS [153].
Limitations of proteomic methods
Like every technology, LC/MS/MS discovery proteomics
has limitations. Firstly, it does not readily detect lowabundance proteins at the desired confidence levels. Sec-
ondly, a given protein more often than not has more
than one function, depending on context, and therefore
could fit into more than one biological process category.
We assigned categories according to what appeared to
be their major function as elaborated by Genecards or
literature. The sensitivity of discovery proteomic analysis
will improve, and will be complemented by an expand-
ing repertoire of proteins that can be individually tar-
geted for analysis. Thirdly, we arbitrarily concentrated
on proteins with FC =/>2. While the assumption that
the role of proteins showing higher FC is more signifi-
cant in blastema and fibroblastema formation makes
sense, the fact that 33% of Xenopus proteins had FC > 2
as opposed to only 14% of axolotl proteins cautions that
proteins with FC < 2 may also play important roles.
Validation of LC/MS/MS data
Validation of β1 integrin, vimentin and β2 dystroglycan
was carried out by immunostaining as described previ-
ously [45]. These proteins were selected because there
were mammalian antibodies available that recognize the
Xenopus versions of these proteins and the antibodies
had been demonstrated to work well for immunostain-
ing. They were also chosen for their expression profiles,
with β2 dystroglycan showing strong down regulation
and vimentin and β1 integrin showing gradual strong up
regulation. The samples were fixed overnight in 2% para-
formaldehyde in 0.8 × PBS and then rinsed with 1.0 ×
PBS before decalcifying for 30 min in Calci-Clear Rapid
(Fisher Scientific, Houston). After decalcification, the
samples were cryoprotected by sequential incubation in
10%, 20% and 30% sucrose in 1 × PBS, then embedded in
a 50:50 mixture of 30% sucrose and Neg 50 frozen sec-
tion medium (Thermo-Fisher Scientific, Waltham, MA,
USA). Sections were cut at 10 μm on a Leica CM1900
cryostat (Leica, Wetzlar, Germany) and incubated in 1×
PBS to remove excess embedding medium, then blocked
for 30 min in a solution of 0.01% Tween-20 and 5% milk
in tris(hydroxymethyl)aminomethane (Tris)-buffered sa-
line. Sections were incubated over night with antibodies
to β1 integrin (clone 8C8), vimentin (clone 147) and dys-
troglycan (clone 7A10) from the Developmental Studies
Hybridoma Bank. The secondary antibody was Alexafluor
488 conjugated goat anti-mouse IgG from Invitrogen.
Immunostained sections were observed under the
20 × objective lens on a Zeiss Axiovert 200 M micro-
scope (Carl Zeiss Microimaging, Thornwood, NY, USA).
Sections were obtained from the hindlimbs of three ani-
mals for each time point. Six images were collected for
each section, from regions located at the tip of the am-
putated limb to just proximal to the plane of amputation
for 5 and 12 dpa samples and across the putative ampu-
tation plane in control sections. Mean pixel intensities
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distributed regions of each image using the measure-
ment package of the Axiovision software. Regions of sec-
tions containing bone were omitted from analysis, as
some bone tissue displayed autofluorescence. Statistical
comparisons were performed using analysis of variance
(ANOVA). A P value < 0.05 was considered statistically
significant.
Additional files
Additional file 1: Table S1. List of P1 and P2 proteins in each of the
ten biological process categories and subcategories, with fold change at
each time point post-amputation.
Additional file 2: Figure 1. Global expression intensity maps for the 10
biological process categories at 1, 5, 7 and 12 dpa. A: Signaling,
Cytoskeleton, B: .Intracellular Transport, Transcription, Translation; C:
Metabolism, Cell Cycle, ECM; D: Cell Protection, Degradation Red = up
regulation; green = down regulation. Level of fold change (FC) is indicated
by color intensity. Accession numbers to the right of columns. Intensities for
some proteins can be 7–10 times the highest and lowest intensities shown.
Additional file 3: Xenopus proteins up or down regulated with
FC =/>2 on one or more dpa.
Additional file 4: Narrative description of functions for Xenopus
proteins up or down regulated by a factor of 2 or more.
Additional file 5: Figure S2. Circos representation of differences in
protein expression during blastema formationin the axolotl (A) and
fibroblastema formation in the Xenopus froglet (B). The outermost circle
shows shows protein expression according to biological process.
Metabolism is the most over-represented biological process category in
the Xenopus data, whereas Cytoskeleton is the most over-represented in
the axolotl data. There were no proteins identified in the Transport category
in the axolotl compared to 70 such proteins in the Xenopus data. The next
circle represents proteins expressed with FC =/>2 (blue) or =/ 4 (pink). The
Xenopus data contained a far higher number of proteins with these fold
differences, especially in the transcription, cytoskeleton and signaling
categories compared to the axolotl data. Progressing inward, the next four
circles in Xenopus reflect the fold change difference (red = down regulation;
green = up regulation; blue = no change) of proteins at 1 dpa, 5 dpa, 7
dpa, and 12 dpa, respectively. In the axolotl, three circles represent FC in
protein expression at 1 dpa, 4 dpa, and 7dpa. The innermost circle represents
the connections between the interacting proteins within the Xenopus and
axolotl data. A comparison of these interactions indicates that the proteomic
composition and protein-protein interactions are much more complex during
formation of the fibroblastema in Xenopus.
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